CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: cytarabine
Accession: CHEBI:28680
browse the term
Definition: A pyrimidine nucleoside in which cytosine is attached to D-arabinofuranose via a beta-N(1)-glycosidic bond. Used mainly in the treatment of leukaemia, especially acute non-lymphoblastic leukaemia, cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. It also has antiviral and immunosuppressant properties.
Synonyms: exact_synonym: 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one
related_synonym: 1-beta-D-Arabinofuranosylcytosine; 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone; Arabinoside C; Cytosine arabinoside; Cytosine-1-beta-D-arabinofuranoside; Formula=C9H13N3O5; InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1; InChIKey=UHDGCWIWMRVCDJ-CCXZUQQUSA-N; SMILES=Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1; ara-C; arabinocytosine; citarabina; cytarabinum; cytosine-beta-D-arabinofuranoside
alt_id: CHEBI:23532; CHEBI:4074; CHEBI:40824
xref: Beilstein:89175; CAS:147-94-4; DrugBank:DB00987; Drug_Central:770; HMDB:HMDB0015122; KEGG:C02961; KEGG:D00168; LINCS:LSM-5470
xref_mesh: MESH:D003561
xref: PDBeChem:AR3; PMID:15492802; Reaxys:89175; Wikipedia:Cytarabine
G
2900026A02Rik
RIKEN cDNA 2900026A02 gene
decreases expression
ISO
Cytarabine results in decreased expression of KIAA1671 mRNA
CTD
PMID:21198554
NCBI chr 5:113,234,189...113,369,158
Ensembl chr 5:113,234,189...113,369,102
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
affects response to substance increases expression
ISO
ABCB1 protein affects the susceptibility to Cytarabine Cytarabine results in increased expression of ABCB1
CTD
PMID:11573427 PMID:17852453
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcc1
ATP-binding cassette, sub-family C member 1
affects response to substance
ISO
ABCC1 protein affects the susceptibility to Cytarabine
CTD
PMID:17852453
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
G
Acap1
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
increases expression
ISO
Cytarabine results in increased expression of ACAP1 mRNA
CTD
PMID:19194470
NCBI chr11:69,772,393...69,786,390
Ensembl chr11:69,772,393...69,786,365
G
Ache
acetylcholinesterase
increases activity multiple interactions
ISO
Cytarabine results in increased activity of ACHE protein betanin inhibits the reaction [Cytarabine results in increased activity of ACHE protein]; thymoquinone inhibits the reaction [Cytarabine results in increased activity of ACHE protein]; Vitamin D inhibits the reaction [Cytarabine results in increased activity of ACHE protein]
CTD
PMID:36419121
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Acta1
actin alpha 1, skeletal muscle
increases expression
ISO
Cytarabine results in increased expression of ACTA1 mRNA
CTD
PMID:21198554
NCBI chr 8:124,618,497...124,621,514
Ensembl chr 8:124,618,508...124,621,490
G
Actc1
actin, alpha, cardiac muscle 1
decreases expression
ISO
Cytarabine results in decreased expression of ACTC1 mRNA
CTD
PMID:21198554
NCBI chr 2:113,877,763...113,883,356
Ensembl chr 2:113,877,763...113,884,029
G
Adam19
ADAM metallopeptidase domain 19
decreases expression
ISO
Cytarabine results in decreased expression of ADAM19 mRNA
CTD
PMID:21198554
NCBI chr11:45,945,329...46,038,174
Ensembl chr11:45,946,819...46,038,170
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
decreases expression
ISO
Cytarabine results in decreased expression of ADAMTS1 mRNA
CTD
PMID:21198554
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Adamts9
ADAM metallopeptidase with thrombospondin type 1 motif 9
decreases expression
ISO
Cytarabine results in decreased expression of ADAMTS9 mRNA
CTD
PMID:21198554
NCBI chr 6:92,749,680...92,921,431
Ensembl chr 6:92,749,680...92,920,473
G
Adgrb3
adhesion G protein-coupled receptor B3
increases expression
ISO
Cytarabine results in increased expression of ADGRB3 mRNA
CTD
PMID:21198554
NCBI chr 1:25,106,557...25,869,338
Ensembl chr 1:25,106,557...25,868,788
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
EXP
[2,2-bis(4-glycidyloxyphenyl)propane co-treated with Cytarabine] results in decreased expression of ADIPOQ mRNA
CTD
PMID:23264188
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Afap1l2
actin filament associated protein 1-like 2
decreases expression
ISO
Cytarabine results in decreased expression of AFAP1L2 mRNA
CTD
PMID:21198554
NCBI chr19:56,900,786...57,017,021
Ensembl chr19:56,900,793...56,996,660
G
Ahi1
Abelson helper integration site 1
increases expression
ISO
Cytarabine results in increased expression of AHI1 protein alternative form
CTD
PMID:19379585
NCBI chr10:20,827,274...20,956,328
Ensembl chr10:20,828,446...20,956,328
G
Ahnak
AHNAK nucleoprotein
decreases expression
ISO
Cytarabine results in decreased expression of AHNAK mRNA
CTD
PMID:21198554
NCBI chr19:8,966,640...9,054,299
Ensembl chr19:8,966,648...9,054,278
G
Aif1l
allograft inflammatory factor 1-like
increases expression
ISO
Cytarabine results in increased expression of AIF1L mRNA
CTD
PMID:21198554
NCBI chr 2:31,840,315...31,863,454
Ensembl chr 2:31,840,151...31,863,454
G
Akr1b7
aldo-keto reductase family 1, member B7
decreases expression
ISO
Cytarabine results in decreased expression of AKR1B15 mRNA
CTD
PMID:21198554
NCBI chr 6:34,389,297...34,400,072
Ensembl chr 6:34,389,269...34,400,077
G
Alpk2
alpha-kinase 2
decreases expression
ISO
Cytarabine results in decreased expression of ALPK2 mRNA
CTD
PMID:21198554
NCBI chr18:65,398,600...65,526,959
Ensembl chr18:65,398,600...65,527,137
G
Angptl2
angiopoietin-like 2
decreases expression
ISO
Cytarabine results in decreased expression of ANGPTL2 mRNA
CTD
PMID:21198554
NCBI chr 2:33,105,963...33,137,737
Ensembl chr 2:33,106,081...33,137,729
G
Anks1
ankyrin repeat and SAM domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of ANKS1A mRNA
CTD
PMID:21198554
NCBI chr17:28,128,273...28,281,753
Ensembl chr17:28,128,280...28,281,749
G
Ano8
anoctamin 8
increases expression
ISO
Cytarabine results in increased expression of ANO8 mRNA
CTD
PMID:21198554
NCBI chr 8:71,928,660...71,938,735
Ensembl chr 8:71,928,663...71,938,607
G
Anxa2
annexin A2
decreases expression increases expression
ISO
Cytarabine results in decreased expression of ANXA2 mRNA Cytarabine results in increased expression of ANXA2 mRNA
CTD
PMID:12165291 PMID:21198554
NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077
G
Anxa6
annexin A6
decreases expression
ISO
Cytarabine results in decreased expression of ANXA6 mRNA
CTD
PMID:21198554
NCBI chr11:54,869,779...54,924,297
Ensembl chr11:54,869,934...54,924,271
G
Anxa8
annexin A8
decreases expression
ISO
Cytarabine results in decreased expression of ANXA8 mRNA
CTD
PMID:21198554
NCBI chr14:33,807,936...33,822,528
Ensembl chr14:33,807,938...33,822,528
G
Aplnr
apelin receptor
decreases expression
ISO
Cytarabine results in decreased expression of APLNR mRNA
CTD
PMID:21198554
NCBI chr 2:84,966,704...84,970,267
Ensembl chr 2:84,966,569...84,970,267
G
Aqp1
aquaporin 1
decreases expression
ISO
Cytarabine results in decreased expression of AQP1 mRNA
CTD
PMID:21198554
NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
G
Arg2
arginase type II
decreases expression
ISO
Cytarabine results in decreased expression of ARG2 mRNA
CTD
PMID:21198554
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
G
Arhgap44
Rho GTPase activating protein 44
decreases expression
ISO
Cytarabine results in decreased expression of ARHGAP44 mRNA
CTD
PMID:21198554
NCBI chr11:64,892,865...65,053,779
Ensembl chr11:64,892,865...65,053,787
G
Arhgdib
Rho, GDP dissociation inhibitor beta
decreases expression
ISO
Cytarabine results in decreased expression of ARHGDIB mRNA
CTD
PMID:21198554
NCBI chr 6:136,900,653...136,918,895
Ensembl chr 6:136,900,653...136,918,897
G
Arhgef3
Rho guanine nucleotide exchange factor 3
decreases expression
ISO
Cytarabine results in decreased expression of ARHGEF3 mRNA
CTD
PMID:21198554
NCBI chr14:26,836,418...27,125,873
Ensembl chr14:26,836,856...27,125,868
G
Arl6ip5
ADP-ribosylation factor-like 6 interacting protein 5
increases expression
ISO
Cytarabine results in increased expression of ARL6IP5 protein
CTD
PMID:16430862
NCBI chr 6:97,187,753...97,210,276
Ensembl chr 6:97,187,650...97,210,276
G
Art4
ADP-ribosyltransferase 4
decreases expression
ISO
Cytarabine results in decreased expression of ART4 mRNA
CTD
PMID:21198554
NCBI chr 6:136,825,449...136,834,598
Ensembl chr 6:136,825,449...136,834,731
G
Art5
ADP-ribosyltransferase 5
decreases expression
ISO
Cytarabine results in decreased expression of ART5 mRNA
CTD
PMID:21198554
NCBI chr 7:101,746,086...101,752,052
Ensembl chr 7:101,746,086...101,758,696
G
Atf3
activating transcription factor 3
decreases expression increases expression
ISO
Cytarabine results in decreased expression of ATF3 mRNA Cytarabine results in increased expression of ATF3 mRNA
CTD
PMID:21198554 PMID:33770205
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
G
Atl1
atlastin GTPase 1
increases expression
ISO
Cytarabine results in increased expression of ATL1 mRNA
CTD
PMID:21198554
NCBI chr12:69,939,879...70,010,859
Ensembl chr12:69,939,388...70,013,191
G
Atn1
atrophin 1
increases expression
ISO
Cytarabine results in increased expression of ATN1 mRNA
CTD
PMID:21198554
NCBI chr 6:124,719,507...124,733,450
Ensembl chr 6:124,719,507...124,733,487 Ensembl chr 6:124,719,507...124,733,487
G
Atp10d
ATPase, class V, type 10D
increases expression
ISO
Cytarabine results in increased expression of ATP10D mRNA
CTD
PMID:19194470
NCBI chr 5:72,360,672...72,456,114
Ensembl chr 5:72,360,672...72,456,118
G
Atp1b1
ATPase, Na+/K+ transporting, beta 1 polypeptide
decreases expression
ISO
Cytarabine results in decreased expression of ATP1B1 mRNA
CTD
PMID:21198554
NCBI chr 1:164,264,668...164,285,924
Ensembl chr 1:164,264,678...164,285,924
G
Atp7b
ATPase, Cu++ transporting, beta polypeptide
decreases expression
ISO
Cytarabine results in decreased expression of ATP7B mRNA
CTD
PMID:21198554
NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321
G
Atp8b4
ATPase, class I, type 8B, member 4
decreases expression
ISO
Cytarabine results in decreased expression of ATP8B4 mRNA
CTD
PMID:21198554
NCBI chr 2:126,162,893...126,342,589
Ensembl chr 2:126,162,893...126,342,594
G
Axl
AXL receptor tyrosine kinase
decreases expression
ISO
Cytarabine results in decreased expression of AXL mRNA
CTD
PMID:21198554
NCBI chr 7:25,455,925...25,488,502
Ensembl chr 7:25,456,698...25,488,130
G
B2m
beta-2 microglobulin
increases expression
ISO
Cytarabine results in increased expression of B2M protein
CTD
PMID:11096300
NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564
G
B4galt7
beta-1,4-galactosyltransferase 7
decreases expression
ISO
Cytarabine results in decreased expression of B4GALT7 mRNA
CTD
PMID:21198554
NCBI chr13:55,747,709...55,758,258
Ensembl chr13:55,747,709...55,758,256
G
Bag3
BCL2-associated athanogene 3
decreases expression
ISO
Cytarabine results in decreased expression of BAG3 mRNA
CTD
PMID:21198554
NCBI chr 7:128,125,307...128,148,705
Ensembl chr 7:128,125,340...128,148,705
G
Baiap2l1
BAI1-associated protein 2-like 1
decreases expression
ISO
Cytarabine results in decreased expression of BAIAP2L1 mRNA
CTD
PMID:21198554
NCBI chr 5:144,201,335...144,294,922
Ensembl chr 5:144,201,336...144,294,922
G
Bax
BCL2-associated X protein
increases expression
ISO
Cytarabine results in increased expression of BAX mRNA [Cytarabine results in increased expression of TP53 protein] which results in increased expression of BAX protein; Cytarabine results in increased expression of BAX protein
CTD
PMID:10200513 PMID:15203180 PMID:16129037 PMID:17490525
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bbc3
BCL2 binding component 3
affects response to substance
EXP
BBC3 protein affects the susceptibility to Cytarabine
CTD
PMID:20477944
NCBI chr 7:16,042,307...16,052,130
Ensembl chr 7:16,042,318...16,052,130
G
Bcar3
breast cancer anti-estrogen resistance 3
decreases expression
ISO
Cytarabine results in decreased expression of BCAR3 mRNA
CTD
PMID:21198554
NCBI chr 3:122,213,406...122,323,840
Ensembl chr 3:122,087,785...122,323,840
G
Bche
butyrylcholinesterase
multiple interactions increases activity
ISO
betanin inhibits the reaction [Cytarabine results in increased activity of BCHE protein]
CTD
PMID:36419121
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Bcl2
B cell leukemia/lymphoma 2
multiple interactions decreases expression increases degradation
ISO
[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein; BCL2 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein]; edelfosine promotes the reaction [Cytarabine results in decreased expression of BCL2 protein] Cytarabine results in decreased expression of BCL2 mRNA; Cytarabine results in decreased expression of BCL2 protein Cytarabine results in increased degradation of BCL2 protein
CTD
PMID:1450413 PMID:8840993 PMID:9295281 PMID:12853972 PMID:16129037 PMID:17490525 PMID:21182165 More...
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
multiple interactions
ISO
BCL2L1 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2L1 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein]
CTD
PMID:8840993
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bhlhe22
basic helix-loop-helix family, member e22
increases expression
ISO
Cytarabine results in increased expression of BHLHE22 mRNA
CTD
PMID:21198554
NCBI chr 3:18,108,489...18,111,678
Ensembl chr 3:18,108,338...18,111,681
G
Bid
BH3 interacting domain death agonist
multiple interactions
ISO
[Cytarabine co-treated with TNFSF10 protein] results in increased expression of BID protein
CTD
PMID:12780785
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
G
Bin2
bridging integrator 2
increases expression
ISO
Cytarabine results in increased expression of BIN2 mRNA
CTD
PMID:19194470
NCBI chr15:100,538,963...100,567,384
Ensembl chr15:100,538,958...100,567,434
G
Bmp4
bone morphogenetic protein 4
decreases expression
ISO
Cytarabine results in decreased expression of BMP4 mRNA
CTD
PMID:21198554
NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126
G
Bmp5
bone morphogenetic protein 5
decreases expression
ISO
Cytarabine results in decreased expression of BMP5 mRNA
CTD
PMID:21198554
NCBI chr 9:75,682,647...75,807,598
Ensembl chr 9:75,682,646...75,807,592
G
Bnc1
basonuclin zinc finger protein 1
decreases expression
ISO
Cytarabine results in decreased expression of BNC1 mRNA
CTD
PMID:21198554
NCBI chr 7:81,616,401...81,642,047
Ensembl chr 7:81,616,401...81,642,055
G
Bnc2
basonuclin zinc finger protein 2
decreases expression
ISO
Cytarabine results in decreased expression of BNC2 mRNA
CTD
PMID:21198554
NCBI chr 4:84,185,041...84,593,236
Ensembl chr 4:84,193,332...84,593,512
G
Bora
bora, aurora kinase A activator
decreases expression
ISO
Cytarabine results in decreased expression of BORA mRNA
CTD
PMID:17374387
NCBI chr14:99,283,880...99,311,976
Ensembl chr14:99,283,658...99,311,976
G
Bpnt2
3'(2'), 5'-bisphosphate nucleotidase 2
decreases expression
ISO
Cytarabine results in decreased expression of BPNT2 mRNA
CTD
PMID:21198554
NCBI chr 4:4,762,484...4,793,306
Ensembl chr 4:4,762,484...4,793,355
G
Brca2
breast cancer 2, early onset
increases expression
ISO
Cytarabine results in increased expression of BRCA2 mRNA
CTD
PMID:19194470
NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
increases expression
EXP
Cytarabine results in increased expression of BSCL2 mRNA
CTD
PMID:22003191
NCBI chr19:8,814,831...8,826,047
Ensembl chr19:8,814,831...8,826,047
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
ISO
Cytarabine results in decreased expression of BST2 mRNA
CTD
PMID:21198554
NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100
G
Btg2
BTG anti-proliferation factor 2
increases expression
EXP
Cytarabine results in increased expression of BTG2 mRNA
CTD
PMID:21382384
NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
G
C2cd2
C2 calcium-dependent domain containing 2
decreases expression
ISO
Cytarabine results in decreased expression of C2CD2 mRNA
CTD
PMID:21198554
NCBI chr16:97,656,409...97,727,248
Ensembl chr16:97,656,409...97,763,798
G
C3ar1
complement component 3a receptor 1
increases expression
ISO
Cytarabine results in increased expression of C3AR1 mRNA
CTD
PMID:19194470
NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
G
Cab39l
calcium binding protein 39-like
decreases expression
ISO
Cytarabine results in decreased expression of CAB39L mRNA
CTD
PMID:21198554
NCBI chr14:59,678,400...59,786,353
Ensembl chr14:59,678,421...59,823,213
G
Calb1
calbindin 1
decreases expression
ISO
Cytarabine results in decreased expression of CALB1 protein
CTD
PMID:22212197
NCBI chr 4:15,881,264...15,906,709
Ensembl chr 4:15,881,264...15,908,064
G
Calb2
calbindin 2
decreases expression
ISO
Cytarabine results in decreased expression of CALB2 mRNA
CTD
PMID:21198554
NCBI chr 8:110,869,158...110,894,844
Ensembl chr 8:110,864,134...110,894,842
G
Calcr
calcitonin receptor
increases response to substance
ISO
CALCR results in increased susceptibility to Cytarabine
CTD
PMID:21755009
NCBI chr 6:3,685,678...3,764,713
Ensembl chr 6:3,685,680...3,764,714
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
increases expression
ISO
Cytarabine results in increased expression of CAMK2N1 mRNA
CTD
PMID:21198554
NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
G
Capn1
calpain 1
decreases expression
ISO
Cytarabine results in decreased expression of CAPN1 mRNA
CTD
PMID:21198554
NCBI chr19:6,038,573...6,065,855
Ensembl chr19:6,038,573...6,065,927
G
Car12
carbonic anhydrase 12
decreases expression
ISO
Cytarabine results in decreased expression of CA12 mRNA
CTD
PMID:21198554
NCBI chr 9:66,619,026...66,674,127
Ensembl chr 9:66,620,968...66,674,127
G
Carmil1
capping protein regulator and myosin 1 linker 1
decreases expression
ISO
Cytarabine results in decreased expression of CARMIL1 mRNA
CTD
PMID:21198554
NCBI chr13:24,196,464...24,464,983
Ensembl chr13:24,196,327...24,464,778
G
Casp3
caspase 3
multiple interactions increases expression increases activity
ISO
[Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP3 protein; BCL2 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2L1 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein]; Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein Cytarabine results in increased expression of CASP3 protein Cytarabine results in increased activity of CASP3 protein
CTD
PMID:8840993 PMID:12780785 PMID:12781215 PMID:14766721 PMID:22212197 PMID:25003661 More...
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
multiple interactions
ISO
[Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; Cytarabine promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Cytarabine results in increased expression of and results in increased cleavage of CASP8 protein
CTD
PMID:12780785 PMID:18549619 PMID:22010212
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cavin1
caveolae associated 1
decreases expression
ISO
Cytarabine results in decreased expression of CAVIN1 mRNA
CTD
PMID:21198554
NCBI chr11:100,847,562...100,861,443
Ensembl chr11:100,847,559...100,861,713
G
Cavin3
caveolae associated 3
decreases expression
ISO
Cytarabine results in decreased expression of CAVIN3 mRNA
CTD
PMID:21198554
NCBI chr 7:105,129,823...105,131,404
Ensembl chr 7:105,129,290...105,131,507
G
Ccdc102a
coiled-coil domain containing 102A
decreases expression
ISO
Cytarabine results in decreased expression of CCDC102A mRNA
CTD
PMID:21198554
NCBI chr 8:95,629,497...95,644,726
Ensembl chr 8:95,629,497...95,644,726
G
Ccdc112
coiled-coil domain containing 112
increases expression
ISO
Cytarabine results in increased expression of CCDC112 mRNA
CTD
PMID:21198554
NCBI chr18:46,415,218...46,445,016
Ensembl chr18:46,415,218...46,444,995
G
Ccdc15
coiled-coil domain containing 15
increases expression
ISO
Cytarabine results in increased expression of CCDC15 mRNA
CTD
PMID:21198554
NCBI chr 9:37,178,758...37,262,508
Ensembl chr 9:37,187,131...37,259,728
G
Cckbr
cholecystokinin B receptor
decreases expression
ISO
Cytarabine results in decreased expression of CCKBR mRNA
CTD
PMID:21198554
NCBI chr 7:105,075,201...105,085,546
Ensembl chr 7:105,074,938...105,120,105
G
Ccnd3
cyclin D3
decreases expression
ISO
Cytarabine results in decreased expression of CCND3 mRNA
CTD
PMID:21198554
NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616
G
Ccne2
cyclin E2
increases expression
ISO
Cytarabine results in increased expression of CCNE2 mRNA
CTD
PMID:21198554
NCBI chr 4:11,190,489...11,204,781
Ensembl chr 4:11,191,351...11,204,779
G
Ccng1
cyclin G1
increases expression
ISO
Cytarabine results in increased expression of CCNG1 mRNA
CTD
PMID:14766721 PMID:15203180
NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138
G
Cd44
CD44 antigen
decreases expression
ISO
Cytarabine results in decreased expression of CD44 mRNA
CTD
PMID:21198554
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
G
Cd8a
CD8 subunit alpha
increases expression
ISO
Cytarabine results in increased expression of CD8A mRNA
CTD
PMID:19194470
NCBI chr 6:71,350,411...71,356,155
Ensembl chr 6:71,350,411...71,356,157
G
Cdc42ep5
CDC42 effector protein 5
decreases expression
ISO
Cytarabine results in decreased expression of CDC42EP5 mRNA
CTD
PMID:21198554
NCBI chr 7:4,154,259...4,167,830
Ensembl chr 7:4,154,259...4,167,859
G
Cdca8
cell division cycle associated 8
decreases expression
ISO
Cytarabine results in decreased expression of CDCA8 mRNA
CTD
PMID:17374387
NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104
G
Cdh11
cadherin 11
decreases expression
ISO
Cytarabine results in decreased expression of CDH11 mRNA
CTD
PMID:21198554
NCBI chr 8:103,358,727...103,512,125
Ensembl chr 8:103,358,727...103,512,274
G
Cdh3
cadherin 3
decreases expression
ISO
Cytarabine results in decreased expression of CDH3 mRNA
CTD
PMID:21198554
NCBI chr 8:107,237,484...107,283,543
Ensembl chr 8:107,237,523...107,283,929
G
Cdk5r1
cyclin dependent kinase 5, regulatory subunit 1
increases expression
ISO
Cytarabine results in increased expression of CDK5R1 mRNA
CTD
PMID:33770205
NCBI chr11:80,367,849...80,372,010
Ensembl chr11:80,367,849...80,372,010
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
multiple interactions increases expression
ISO
[fludarabine co-treated with Cytarabine co-treated with docetaxel] results in increased expression of CDKN1A protein; Caffeine inhibits the reaction [Cytarabine results in increased expression of CDKN1A protein] Cytarabine results in increased expression of CDKN1A mRNA; Cytarabine results in increased expression of CDKN1A protein
CTD
PMID:9703875 PMID:14766721 PMID:15203180 PMID:17977830 PMID:33770205
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn1c
cyclin dependent kinase inhibitor 1C
decreases expression
ISO
Cytarabine results in decreased expression of CDKN1C mRNA
CTD
PMID:21198554
NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787
G
Cebpd
CCAAT/enhancer binding protein delta
decreases expression
ISO
Cytarabine results in decreased expression of CEBPD mRNA
CTD
PMID:21198554
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
G
Celf3
CUGBP, Elav-like family member 3
increases expression
ISO
Cytarabine results in increased expression of CELF3 mRNA
CTD
PMID:21198554
NCBI chr 3:94,385,581...94,405,822
Ensembl chr 3:94,385,602...94,399,505
G
Cemip
cell migration inducing protein, hyaluronan binding
decreases expression
ISO
Cytarabine results in decreased expression of CEMIP mRNA
CTD
PMID:21198554
NCBI chr 7:83,582,065...83,735,893
Ensembl chr 7:83,582,065...83,735,710
G
Chat
choline O-acetyltransferase
increases activity
ISO
Cytarabine results in increased activity of CHAT protein
CTD
PMID:2900045
NCBI chr14:32,130,160...32,187,866
Ensembl chr14:32,130,160...32,187,946
G
Chn1
chimerin 1
decreases expression
ISO
Cytarabine results in decreased expression of CHN1 mRNA
CTD
PMID:21198554
NCBI chr 2:73,441,004...73,605,723
Ensembl chr 2:73,441,004...73,605,690
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
decreases expression
ISO
Cytarabine results in decreased expression of CITED2 mRNA
CTD
PMID:21198554
NCBI chr10:17,598,452...17,601,422
Ensembl chr10:17,598,966...17,601,422
G
Ckb
creatine kinase, brain
increases expression
ISO
Cytarabine results in increased expression of CKB mRNA
CTD
PMID:21198554
NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
G
Cks2
CDC28 protein kinase regulatory subunit 2
decreases expression
ISO
Cytarabine results in decreased expression of CKS2 mRNA
CTD
PMID:17374387
NCBI chr13:51,799,268...51,804,698
Ensembl chr13:51,799,268...51,804,696
G
Cldn15
claudin 15
decreases expression
ISO
Cytarabine results in decreased expression of CLDN15 mRNA
CTD
PMID:21198554
NCBI chr 5:136,996,723...137,004,699
Ensembl chr 5:136,995,470...137,004,712
G
Clec1b
C-type lectin domain family 1, member b
decreases expression
ISO
Cytarabine results in decreased expression of CLEC1B mRNA
CTD
PMID:21198554
NCBI chr 6:129,374,260...129,382,376
Ensembl chr 6:129,374,260...129,386,298
G
Cnih2
cornichon family AMPA receptor auxiliary protein 2
increases expression
ISO
Cytarabine results in increased expression of CNIH2 mRNA
CTD
PMID:21198554
NCBI chr19:5,142,896...5,148,549
Ensembl chr19:5,142,896...5,148,549
G
Cnr1
cannabinoid receptor 1
increases expression
ISO
Cytarabine results in increased expression of CNR1 mRNA
CTD
PMID:21198554
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Cntfr
ciliary neurotrophic factor receptor
increases expression
ISO
Cytarabine results in increased expression of CNTFR mRNA
CTD
PMID:21198554
NCBI chr 4:41,657,498...41,697,091
Ensembl chr 4:41,657,498...41,697,089
G
Cntrl
centriolin
increases expression
ISO
Cytarabine results in increased expression of CNTRL mRNA
CTD
PMID:21198554
NCBI chr 2:34,999,504...35,068,834
Ensembl chr 2:34,999,504...35,068,834
G
Cobll1
Cobl-like 1
decreases expression
ISO
Cytarabine results in decreased expression of COBLL1 mRNA
CTD
PMID:21198554
NCBI chr 2:64,918,683...65,069,742
Ensembl chr 2:64,918,683...65,069,747
G
Col13a1
collagen, type XIII, alpha 1
decreases expression
ISO
Cytarabine results in decreased expression of COL13A1 mRNA
CTD
PMID:21198554
NCBI chr10:61,674,013...61,814,985
Ensembl chr10:61,674,015...61,814,887
G
Col18a1
collagen, type XVIII, alpha 1
decreases expression
ISO
Cytarabine results in decreased expression of COL18A1 mRNA
CTD
PMID:21198554
NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382
G
Col1a1
collagen, type I, alpha 1
decreases expression
ISO
Cytarabine results in decreased expression of COL1A1 mRNA
CTD
PMID:21198554
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col1a2
collagen, type I, alpha 2
decreases expression
ISO
Cytarabine results in decreased expression of COL1A2 mRNA
CTD
PMID:21198554
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
G
Col3a1
collagen, type III, alpha 1
decreases expression
ISO
Cytarabine results in decreased expression of COL3A1 mRNA
CTD
PMID:21198554
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Col5a1
collagen, type V, alpha 1
decreases expression
ISO
Cytarabine results in decreased expression of COL5A1 mRNA
CTD
PMID:21198554
NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526
G
Col5a2
collagen, type V, alpha 2
decreases expression
ISO
Cytarabine results in decreased expression of COL5A2 mRNA
CTD
PMID:21198554
NCBI chr 1:45,413,491...45,542,442
Ensembl chr 1:45,413,481...45,542,442
G
Col6a2
collagen, type VI, alpha 2
decreases expression
ISO
Cytarabine results in decreased expression of COL6A2 mRNA
CTD
PMID:21198554
NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464
G
Col6a3
collagen, type VI, alpha 3
decreases expression
ISO
Cytarabine results in decreased expression of COL6A3 mRNA
CTD
PMID:21198554
NCBI chr 1:90,694,582...90,771,710
Ensembl chr 1:90,693,645...90,771,693
G
Col9a1
collagen, type IX, alpha 1
increases expression
ISO
Cytarabine results in increased expression of COL9A1 mRNA
CTD
PMID:21198554
NCBI chr 1:24,216,670...24,291,819
Ensembl chr 1:24,216,691...24,291,765
G
Colec12
collectin sub-family member 12
decreases expression
ISO
Cytarabine results in decreased expression of COLEC12 mRNA
CTD
PMID:21198554
NCBI chr18:9,707,648...9,877,995
Ensembl chr18:9,707,595...9,882,644
G
Cpz
carboxypeptidase Z
decreases expression
ISO
Cytarabine results in decreased expression of CPZ mRNA
CTD
PMID:21198554
NCBI chr 5:35,659,562...35,682,970
Ensembl chr 5:35,659,562...35,683,042
G
Crabp1
cellular retinoic acid binding protein I
increases expression
ISO
Cytarabine results in increased expression of CRABP1 mRNA
CTD
PMID:21198554
NCBI chr 9:54,672,032...54,680,394
Ensembl chr 9:54,672,032...54,680,394
G
Crispld2
cysteine-rich secretory protein LCCL domain containing 2
decreases expression
ISO
Cytarabine results in decreased expression of CRISPLD2 mRNA
CTD
PMID:21198554
NCBI chr 8:120,719,177...120,779,533
Ensembl chr 8:120,719,177...120,779,532
G
Crtap
cartilage associated protein
decreases expression
ISO
Cytarabine results in decreased expression of CRTAP mRNA
CTD
PMID:21198554
NCBI chr 9:114,204,204...114,219,743
Ensembl chr 9:114,204,202...114,219,743
G
Cryab
crystallin, alpha B
decreases expression
ISO
Cytarabine results in decreased expression of CRYAB mRNA
CTD
PMID:21198554
NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936
G
Csnk1d
casein kinase 1, delta
decreases expression
ISO
Cytarabine results in decreased expression of CSNK1D mRNA
CTD
PMID:21198554
NCBI chr11:120,848,535...120,882,180
Ensembl chr11:120,849,816...120,882,156
G
Csrnp1
cysteine-serine-rich nuclear protein 1
decreases expression
ISO
Cytarabine results in decreased expression of AXUD1 mRNA
CTD
PMID:21198554
NCBI chr 9:119,800,229...119,813,808
Ensembl chr 9:119,800,229...119,813,724
G
Ctsh
cathepsin H
decreases expression
ISO
Cytarabine results in decreased expression of CTSH mRNA
CTD
PMID:21198554
NCBI chr 9:89,936,320...89,958,148
Ensembl chr 9:89,936,205...89,958,142
G
Ctsl
cathepsin L
decreases expression
ISO
Cytarabine results in decreased expression of CTSL mRNA
CTD
PMID:21198554
NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression
ISO
Cytarabine results in increased expression of CXCR4 mRNA
CTD
PMID:19194470 PMID:21198554
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
G
Cyb5a
cytochrome b5 type A (microsomal)
decreases expression
ISO
Cytarabine results in decreased expression of CYB5A mRNA
CTD
PMID:21198554
NCBI chr18:84,869,463...84,897,996
Ensembl chr18:84,856,829...84,897,996
G
Cyb5d1
cytochrome b5 domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of CYB5D1 mRNA
CTD
PMID:21198554
NCBI chr11:69,281,756...69,287,005
Ensembl chr11:69,282,751...69,286,457
G
Cyb5r2
cytochrome b5 reductase 2
decreases expression
ISO
Cytarabine results in decreased expression of CYB5R2 mRNA
CTD
PMID:21198554
NCBI chr 7:107,347,653...107,357,407
Ensembl chr 7:107,347,662...107,357,239
G
Cyba
cytochrome b-245, alpha polypeptide
decreases expression
ISO
Cytarabine results in decreased expression of CYBA mRNA
CTD
PMID:21198554
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
decreases expression
ISO
Cytarabine results in decreased expression of CYP27A1 mRNA
CTD
PMID:21198554
NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051
G
Cyp4x1
cytochrome P450, family 4, subfamily x, polypeptide 1
decreases expression
ISO
Cytarabine results in decreased expression of CYP4X1 mRNA
CTD
PMID:21198554
NCBI chr 4:114,963,518...114,991,276
Ensembl chr 4:114,963,520...114,991,478
G
Cyth1
cytohesin 1
increases expression
ISO
Cytarabine results in increased expression of CYTH1 mRNA
CTD
PMID:19194470
NCBI chr11:118,054,996...118,139,452
Ensembl chr11:118,022,845...118,139,386
G
Dab2
disabled 2, mitogen-responsive phosphoprotein
decreases expression
ISO
Cytarabine results in decreased expression of DAB2 mRNA
CTD
PMID:21198554
NCBI chr15:6,329,269...6,470,196
Ensembl chr15:6,329,269...6,470,193
G
Dalrd3
DALR anticodon binding domain containing 3
decreases expression
ISO
Cytarabine results in decreased expression of DALRD3 mRNA
CTD
PMID:19194470
NCBI chr 9:108,444,710...108,449,972
Ensembl chr 9:108,447,085...108,449,973
G
Dbn1
drebrin 1
decreases expression
ISO
Cytarabine results in decreased expression of DBN1 mRNA
CTD
PMID:19194470
NCBI chr13:55,621,241...55,635,874
Ensembl chr13:55,621,242...55,635,924
G
Dck
deoxycytidine kinase
affects binding decreases response to substance
ISO
Cytarabine binds to DCK protein DCK gene polymorphism results in decreased susceptibility to Cytarabine Cytarabine binds to Dck protein
CTD RGD
PMID:1318170 PMID:18381442 PMID:7532033
RGD:2300399
NCBI chr 5:88,912,872...88,931,136
Ensembl chr 5:88,912,855...88,931,140
G
Dcn
decorin
decreases expression
ISO
Cytarabine results in decreased expression of DCN mRNA
CTD
PMID:21198554
NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
G
Ddr2
discoidin domain receptor family, member 2
decreases expression
ISO
Cytarabine results in decreased expression of DDR2 mRNA
CTD
PMID:21198554
NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331
G
Dennd1a
DENN domain containing 1A
increases expression
ISO
Cytarabine results in increased expression of DENND1A mRNA
CTD
PMID:19194470
NCBI chr 2:37,689,002...38,177,417
Ensembl chr 2:37,689,003...38,177,402
G
Deptor
DEP domain containing MTOR-interacting protein
decreases expression
ISO
Cytarabine results in decreased expression of DEPTOR mRNA
CTD
PMID:21198554
NCBI chr15:54,975,824...55,122,667
Ensembl chr15:54,975,713...55,122,667
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
ISO
Cytarabine results in decreased expression of DHCR24 mRNA
CTD
PMID:21198554
NCBI chr 4:106,418,279...106,446,310
Ensembl chr 4:106,418,235...106,446,310
G
Dhfr
dihydrofolate reductase
increases expression
ISO
Cytarabine results in increased expression of DHFR mRNA
CTD
PMID:19194470
NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
G
Disp3
dispatched RND transporter family member 3
increases expression
ISO
Cytarabine results in increased expression of DISP3 mRNA
CTD
PMID:21198554
NCBI chr 4:148,320,890...148,372,653
Ensembl chr 4:148,324,721...148,372,422
G
Dnah2
dynein, axonemal, heavy chain 2
decreases expression
ISO
Cytarabine results in decreased expression of DNAH2 mRNA
CTD
PMID:21198554
NCBI chr11:69,311,635...69,439,934
Ensembl chr11:69,311,635...69,439,936
G
Dok4
docking protein 4
decreases expression
ISO
Cytarabine results in decreased expression of DOK4 mRNA
CTD
PMID:21198554
NCBI chr 8:95,590,456...95,602,940
Ensembl chr 8:95,590,456...95,602,958
G
Dsc2
desmocollin 2
decreases expression
ISO
Cytarabine results in decreased expression of DSC2 mRNA
CTD
PMID:21198554
NCBI chr18:20,163,690...20,192,611
Ensembl chr18:20,163,690...20,192,611
G
Dsc3
desmocollin 3
decreases expression
ISO
Cytarabine results in decreased expression of DSC3 mRNA
CTD
PMID:21198554
NCBI chr18:20,093,987...20,135,465
Ensembl chr18:20,093,987...20,135,408
G
Dusp4
dual specificity phosphatase 4
decreases expression
ISO
Cytarabine results in decreased expression of DUSP4 mRNA
CTD
PMID:19194470
NCBI chr 8:35,274,448...35,289,106
Ensembl chr 8:35,274,451...35,287,048
G
E2f8
E2F transcription factor 8
increases expression
ISO
Cytarabine results in increased expression of E2F8 mRNA
CTD
PMID:33770205
NCBI chr 7:48,516,177...48,531,821
Ensembl chr 7:48,516,177...48,531,344
G
Ear6
eosinophil-associated, ribonuclease A family, member 6
increases expression
ISO
Cytarabine results in increased expression of RNASE2 mRNA
CTD
PMID:19194470
NCBI chr14:52,091,225...52,092,100
Ensembl chr14:52,091,156...52,092,100
G
Edn1
endothelin 1
multiple interactions
ISO EXP
EDN1 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine] EDN1 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]
CTD
PMID:24184161
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Eef2
eukaryotic translation elongation factor 2
decreases expression
ISO
Cytarabine results in decreased expression of EEF2 mRNA
CTD
PMID:21198554
NCBI chr10:81,012,465...81,018,343
Ensembl chr10:81,012,465...81,018,332
G
Efemp2
epidermal growth factor-containing fibulin-like extracellular matrix protein 2
decreases expression
ISO
Cytarabine results in decreased expression of EFEMP2 mRNA
CTD
PMID:21198554
NCBI chr19:5,523,974...5,532,548
Ensembl chr19:5,523,982...5,532,545
G
Efhd1
EF hand domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of EFHD1 mRNA
CTD
PMID:21198554
NCBI chr 1:87,192,075...87,238,563
Ensembl chr 1:87,192,085...87,238,561
G
Efna1
ephrin A1
decreases expression
ISO
Cytarabine results in decreased expression of EFNA1 mRNA
CTD
PMID:21198554
NCBI chr 3:89,179,037...89,188,258
Ensembl chr 3:89,179,040...89,188,449
G
Egfem1
EGF-like and EMI domain containing 1
increases expression
ISO
Cytarabine results in increased expression of EGFEM1P mRNA
CTD
PMID:21198554
NCBI chr 3:29,135,695...29,831,923
Ensembl chr 3:29,136,172...29,745,358
G
Egfl6
EGF-like-domain, multiple 6
decreases expression
ISO
Cytarabine results in decreased expression of EGFL6 mRNA
CTD
PMID:21198554
NCBI chr X:165,306,003...165,368,712
Ensembl chr X:165,306,003...165,368,716
G
Egflam
EGF-like, fibronectin type III and laminin G domains
decreases expression
ISO
Cytarabine results in decreased expression of EGFLAM mRNA
CTD
PMID:21198554
NCBI chr15:7,235,598...7,428,203
Ensembl chr15:7,235,601...7,427,876
G
Eif4h
eukaryotic translation initiation factor 4H
decreases expression
ISO
Cytarabine results in decreased expression of EIF4H mRNA
CTD
PMID:21198554
NCBI chr 5:134,648,726...134,668,263
Ensembl chr 5:134,648,575...134,668,344
G
Eno3
enolase 3, beta muscle
decreases expression
ISO
Cytarabine results in decreased expression of ENO3 mRNA
CTD
PMID:21198554
NCBI chr11:70,543,973...70,553,339
Ensembl chr11:70,548,028...70,553,339
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
increases expression
ISO
Cytarabine results in increased expression of ENTPD1 mRNA
CTD
PMID:19194470
NCBI chr19:40,600,810...40,730,046
Ensembl chr19:40,600,810...40,730,046
G
Exog
exo/endonuclease G
decreases expression
ISO
Cytarabine results in decreased expression of EXOG mRNA
CTD
PMID:21198554
NCBI chr 9:119,274,026...119,294,584
Ensembl chr 9:119,274,009...119,294,583
G
Ext2
exostosin glycosyltransferase 2
decreases expression
ISO
Cytarabine results in decreased expression of EXT2 mRNA
CTD
PMID:21198554
NCBI chr 2:93,525,978...93,652,913
Ensembl chr 2:93,491,373...93,652,913
G
Ezr
ezrin
decreases expression
ISO
Cytarabine results in decreased expression of EZR mRNA
CTD
PMID:21198554
NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183
G
F2
coagulation factor II
affects expression
ISO
Cytarabine affects the expression of F2 protein
CTD
PMID:12542493
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
Fabp7
fatty acid binding protein 7, brain
increases expression
ISO
Cytarabine results in increased expression of FABP7 mRNA
CTD
PMID:21198554
NCBI chr10:57,661,019...57,664,546
Ensembl chr10:57,660,977...57,664,546
G
Fam111a
family with sequence similarity 111, member A
increases expression
ISO
Cytarabine results in increased expression of FAM111A mRNA
CTD
PMID:19194470
NCBI chr19:12,550,874...12,567,133
Ensembl chr19:12,523,104...12,567,132
G
Fas
Fas cell surface death receptor
increases expression
ISO
Cytarabine results in increased expression of FAS mRNA
CTD
PMID:14766721 PMID:15203180 PMID:33770205
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fbln1
fibulin 1
decreases expression
ISO
Cytarabine results in decreased expression of FBLN1 mRNA
CTD
PMID:21198554
NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736
G
Fbxo2
F-box protein 2
decreases expression
ISO
Cytarabine results in decreased expression of FBXO2 mRNA
CTD
PMID:21198554
NCBI chr 4:148,244,605...148,250,874
Ensembl chr 4:148,245,078...148,250,881
G
Flnc
filamin C, gamma
decreases expression
ISO
Cytarabine results in decreased expression of FLNC mRNA
CTD
PMID:21198554
NCBI chr 6:29,433,150...29,461,888
Ensembl chr 6:29,433,255...29,461,882
G
Flrt2
fibronectin leucine rich transmembrane protein 2
decreases expression
ISO
Cytarabine results in decreased expression of FLRT2 mRNA
CTD
PMID:21198554
NCBI chr12:95,658,780...95,751,989
Ensembl chr12:95,659,000...95,751,989
G
Fmo1
flavin containing monooxygenase 1
decreases expression
ISO
Cytarabine results in decreased expression of FMO1 mRNA
CTD
PMID:21198554
NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
G
Fmo4
flavin containing monooxygenase 4
decreases expression
ISO
Cytarabine results in decreased expression of FMO4 mRNA
CTD
PMID:21198554
NCBI chr 1:162,620,757...162,643,788
Ensembl chr 1:162,620,757...162,641,541
G
Frzb
frizzled-related protein
decreases expression
ISO
Cytarabine results in decreased expression of FRZB mRNA
CTD
PMID:21198554
NCBI chr 2:80,242,314...80,277,740
Ensembl chr 2:80,242,314...80,277,969
G
Fsip1
fibrous sheath-interacting protein 1
increases expression
ISO
Cytarabine results in increased expression of FSIP1 mRNA
CTD
PMID:21198554
NCBI chr 2:117,960,742...118,087,468
Ensembl chr 2:117,960,905...118,087,447
G
Fyb2
FYN binding protein 2
decreases expression
ISO
Cytarabine results in decreased expression of FYB2 mRNA
CTD
PMID:21198554
NCBI chr 4:104,692,431...104,874,061
Ensembl chr 4:104,770,653...104,874,060
G
Fyn
Fyn proto-oncogene
increases expression
ISO
Cytarabine results in increased expression of FYN mRNA
CTD
PMID:21198554
NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377
G
Gabarapl1
GABA type A receptor associated protein like 1
decreases expression
ISO
Cytarabine results in decreased expression of GABARAPL1 mRNA
CTD
PMID:21198554
NCBI chr 6:129,510,155...129,519,294
Ensembl chr 6:129,510,123...129,519,309
G
Gabrp
gamma-aminobutyric acid type A receptor subunit pi
increases expression
ISO
Cytarabine results in increased expression of GABRP mRNA
CTD
PMID:21198554
NCBI chr11:33,500,781...33,528,978
Ensembl chr11:33,500,781...33,528,959
G
Gadd45a
growth arrest and DNA-damage-inducible 45 alpha
increases expression
ISO
Cytarabine results in increased expression of GADD45A mRNA
CTD
PMID:33770205
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
G
Galnt10
polypeptide N-acetylgalactosaminyltransferase 10
decreases expression
ISO
Cytarabine results in decreased expression of GALNT10 mRNA
CTD
PMID:21198554
NCBI chr11:57,536,268...57,678,327
Ensembl chr11:57,536,268...57,678,340
G
Gap43
growth associated protein 43
increases expression
ISO
Cytarabine results in increased expression of GAP43 mRNA
CTD
PMID:21198554
NCBI chr16:42,068,915...42,161,014
Ensembl chr16:42,068,805...42,161,014
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
decreases activity increases response to substance affects localization
ISO
Cytarabine results in decreased activity of GAPDH protein GAPDH protein results in increased susceptibility to Cytarabine Cytarabine affects the localization of GAPDH protein
CTD
PMID:19628630
NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430
G
Gata5
GATA binding protein 5
decreases expression
ISO
Cytarabine results in decreased expression of GATA5 mRNA
CTD
PMID:21198554
NCBI chr 2:179,966,881...179,977,296
Ensembl chr 2:179,966,926...179,976,492
G
Gbp3
guanylate binding protein 3
decreases expression
ISO
Cytarabine results in decreased expression of GBP4 mRNA
CTD
PMID:21198554
NCBI chr 3:142,265,781...142,278,974
Ensembl chr 3:142,265,787...142,278,970
G
Gca
grancalcin
decreases expression
ISO
Cytarabine results in decreased expression of GCA mRNA
CTD
PMID:21198554
NCBI chr 2:62,494,671...62,524,453
Ensembl chr 2:62,494,629...62,524,453
G
Gcnt2
glucosaminyl (N-acetyl) transferase 2 (I blood group)
decreases expression
ISO
Cytarabine results in decreased expression of GCNT2 mRNA
CTD
PMID:21198554
NCBI chr13:41,013,417...41,114,368
Ensembl chr13:41,013,230...41,114,368
G
Ghr
growth hormone receptor
decreases expression
ISO
Cytarabine results in decreased expression of GHR mRNA
CTD
PMID:21198554
NCBI chr15:3,347,237...3,612,834
Ensembl chr15:3,347,242...3,612,974
G
Gls
glutaminase
decreases expression
ISO
Cytarabine results in decreased expression of GLS mRNA
CTD
PMID:21198554
NCBI chr 1:52,202,608...52,274,168
Ensembl chr 1:52,202,607...52,272,391
G
Gm40318
predicted gene, 40318
increases expression
ISO
Cytarabine results in increased expression of S100P mRNA
CTD
PMID:19194470
NCBI chr 5:36,919,848...36,924,763
Ensembl chr 5:36,919,961...36,924,039
G
Gnb3
guanine nucleotide binding protein (G protein), beta 3
decreases expression
ISO
Cytarabine results in decreased expression of GNB3 mRNA
CTD
PMID:21198554
NCBI chr 6:124,811,203...124,817,238
Ensembl chr 6:124,811,203...124,817,238
G
Gper1
G protein-coupled estrogen receptor 1
decreases expression
ISO
Cytarabine results in decreased expression of GPER1 mRNA
CTD
PMID:21198554
NCBI chr 5:139,408,905...139,413,555
Ensembl chr 5:139,408,906...139,413,555
G
Gpm6a
glycoprotein m6a
increases expression
ISO
Cytarabine results in increased expression of GPM6A mRNA
CTD
PMID:21198554
NCBI chr 8:55,232,469...55,513,913
Ensembl chr 8:55,407,878...55,513,906
G
Gpr19
G protein-coupled receptor 19
increases expression
ISO
Cytarabine results in increased expression of GPR19 mRNA
CTD
PMID:21198554
NCBI chr 6:134,846,055...134,875,157
Ensembl chr 6:134,846,056...134,875,541
G
Gpr83
G protein-coupled receptor 83
decreases expression
ISO
Cytarabine results in decreased expression of GPR83 mRNA
CTD
PMID:21198554
NCBI chr 9:14,771,038...14,782,085
Ensembl chr 9:14,771,506...14,782,085
G
Gprc5c
G protein-coupled receptor, family C, group 5, member C
decreases expression
ISO
Cytarabine results in decreased expression of GPRC5C mRNA
CTD
PMID:21198554
NCBI chr11:114,741,976...114,763,443
Ensembl chr11:114,741,978...114,763,443
G
Gria2
glutamate receptor, ionotropic, AMPA2 (alpha 2)
increases expression
ISO
Cytarabine results in increased expression of GRIA2 mRNA
CTD
PMID:21198554
NCBI chr 3:80,588,757...80,711,534
Ensembl chr 3:80,588,757...80,710,142
G
Grk5
G protein-coupled receptor kinase 5
increases expression
ISO
Cytarabine results in increased expression of GRK5 mRNA
CTD
PMID:19194470
NCBI chr19:60,877,995...61,084,406
Ensembl chr19:60,878,187...61,084,406
G
Grpr
gastrin releasing peptide receptor
decreases expression
ISO
Cytarabine results in decreased expression of GRPR mRNA
CTD
PMID:21198554
NCBI chr X:162,296,900...162,332,732
Ensembl chr X:162,296,900...162,332,673
G
Gstcd
glutathione S-transferase, C-terminal domain containing
increases expression
ISO
Cytarabine results in increased expression of GSTCD mRNA
CTD
PMID:19194470
NCBI chr 3:132,687,511...132,797,800
Ensembl chr 3:132,687,513...132,797,794
G
Gstm1
glutathione S-transferase, mu 1
affects response to substance
ISO
GSTM1 gene polymorphism affects the susceptibility to Cytarabine
CTD
PMID:15713801
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gtpbp1
GTP binding protein 1
increases expression
ISO
Cytarabine results in increased expression of GTPBP1 mRNA
CTD
PMID:19194470
NCBI chr15:79,574,202...79,605,680
Ensembl chr15:79,575,046...79,605,680
G
Gucy1a1
guanylate cyclase 1, soluble, alpha 1
decreases expression
ISO
Cytarabine results in decreased expression of GUCY1A1 mRNA
CTD
PMID:21198554
NCBI chr 3:81,999,734...82,053,253
Ensembl chr 3:81,999,734...82,053,096
G
H1f2
H1.2 linker histone, cluster member
decreases expression
ISO
Cytarabine results in decreased expression of H1-2 mRNA
CTD
PMID:21198554
NCBI chr13:23,922,790...23,923,514
Ensembl chr13:23,922,791...23,924,350
G
H2aj
H2J.A histone
decreases expression
ISO
Cytarabine results in decreased expression of H2AJ mRNA
CTD
PMID:21198554
NCBI chr 6:136,785,246...136,787,072
Ensembl chr 6:136,785,242...136,787,072
G
H2ax
H2A.X variant histone
increases phosphorylation
ISO
Cytarabine results in increased phosphorylation of H2AX protein
CTD
PMID:19628630 PMID:34510228
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
G
H4c14
H4 clustered histone 14
decreases expression
ISO
Cytarabine results in decreased expression of H4C3 mRNA
CTD
PMID:19194470
NCBI chr 3:96,170,250...96,170,633
Ensembl chr 3:96,168,998...96,170,627
G
Hand1
heart and neural crest derivatives expressed 1
decreases expression
ISO
Cytarabine results in decreased expression of HAND1 mRNA
CTD
PMID:21198554
NCBI chr11:57,719,539...57,722,973
Ensembl chr11:57,719,531...57,723,644
G
Hand2
heart and neural crest derivatives expressed 2
decreases expression
ISO
Cytarabine results in decreased expression of HAND2 mRNA
CTD
PMID:21198554
NCBI chr 8:57,774,018...57,777,552
Ensembl chr 8:57,774,018...57,777,668
G
Hapln1
hyaluronan and proteoglycan link protein 1
decreases expression
ISO
Cytarabine results in decreased expression of HAPLN1 mRNA
CTD
PMID:21198554
NCBI chr13:89,688,654...89,759,951
Ensembl chr13:89,687,915...89,759,771
G
Has2
hyaluronan synthase 2
decreases expression
ISO
Cytarabine results in decreased expression of HAS2 mRNA
CTD
PMID:21198554
NCBI chr15:56,529,023...56,557,942
Ensembl chr15:56,529,023...56,557,935
G
Hcfc1r1
host cell factor C1 regulator 1 (XPO1-dependent)
decreases expression
ISO
Cytarabine results in decreased expression of HCFC1R1 mRNA
CTD
PMID:21198554
NCBI chr17:23,892,570...23,894,499
Ensembl chr17:23,892,570...23,894,201
G
Hes5
hes family bHLH transcription factor 5
increases expression
ISO
Cytarabine results in increased expression of HES5 mRNA
CTD
PMID:21198554
NCBI chr 4:155,042,358...155,046,829
Ensembl chr 4:155,045,380...155,046,828
G
Hey1
hairy/enhancer-of-split related with YRPW motif 1
decreases expression
ISO
Cytarabine results in decreased expression of HEY1 mRNA
CTD
PMID:33770205
NCBI chr 3:8,728,419...8,732,098
Ensembl chr 3:8,728,419...8,732,316
G
Hif1a
hypoxia inducible factor 1, alpha subunit
increases expression
EXP
Cytarabine results in increased expression of HIF1A mRNA
CTD
PMID:23264188
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hmgb1
high mobility group box 1
increases secretion decreases response to substance
ISO
Cytarabine results in increased secretion of HMGB1 protein HMGB1 protein results in decreased susceptibility to Cytarabine
CTD
PMID:27807322
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hmgcs2
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2
decreases expression
ISO
Cytarabine results in decreased expression of HMGCS2 mRNA
CTD
PMID:21198554
NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054
G
Hnrnpa3
heterogeneous nuclear ribonucleoprotein A3
decreases expression
ISO
Cytarabine results in decreased expression of HNRNPA3 mRNA
CTD
PMID:21198554
NCBI chr 2:75,489,416...75,499,751
Ensembl chr 2:75,489,605...75,499,751
G
Hoxa2
homeobox A2
increases expression
ISO
Cytarabine results in increased expression of HOXA2 mRNA
CTD
PMID:21198554
NCBI chr 6:52,139,389...52,141,808
Ensembl chr 6:52,139,397...52,141,811
G
Hoxa5
homeobox A5
increases expression
ISO
Cytarabine results in increased expression of HOXA5 mRNA
CTD
PMID:21198554
NCBI chr 6:52,178,768...52,181,437
Ensembl chr 6:52,178,734...52,181,567
G
Hoxb4
homeobox B4
decreases expression
ISO
Cytarabine results in decreased expression of HOXB4 mRNA
CTD
PMID:21198554
NCBI chr11:96,209,093...96,212,464
Ensembl chr11:96,209,093...96,212,464
G
Hoxb6
homeobox B6
decreases expression
ISO
Cytarabine results in decreased expression of HOXB6 mRNA
CTD
PMID:21198554
NCBI chr11:96,183,647...96,192,395
Ensembl chr11:96,183,302...96,192,395
G
Hoxb8
homeobox B8
decreases expression
ISO
Cytarabine results in decreased expression of HOXB8 mRNA
CTD
PMID:21198554
NCBI chr11:96,170,227...96,176,151
Ensembl chr11:96,172,731...96,176,141
G
Hoxc6
homeobox C6
decreases expression
ISO
Cytarabine results in decreased expression of HOXC6 mRNA
CTD
PMID:21198554
NCBI chr15:102,906,658...102,920,314
Ensembl chr15:102,906,689...102,920,313
G
Hoxc8
homeobox C8
decreases expression
ISO
Cytarabine results in decreased expression of HOXC8 mRNA
CTD
PMID:21198554
NCBI chr15:102,898,971...102,902,707
Ensembl chr15:102,899,039...102,902,543
G
Hs3st1
heparan sulfate (glucosamine) 3-O-sulfotransferase 1
decreases expression
ISO
Cytarabine results in decreased expression of HS3ST1 mRNA
CTD
PMID:21198554
NCBI chr 5:39,771,278...39,802,791
Ensembl chr 5:39,771,278...39,912,818
G
Htra1
HtrA serine peptidase 1
decreases expression
ISO
Cytarabine results in decreased expression of HTRA1 mRNA
CTD
PMID:21198554
NCBI chr 7:130,537,933...130,587,388
Ensembl chr 7:130,537,841...130,587,390
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression
ISO
Cytarabine results in decreased expression of IGFBP3 mRNA
CTD
PMID:21198554
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Igfbp5
insulin-like growth factor binding protein 5
decreases expression
ISO
Cytarabine results in decreased expression of IGFBP5 mRNA
CTD
PMID:21198554
NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043
G
Il6
interleukin 6
increases expression
ISO
Cytarabine results in increased expression of IL6 protein
CTD
PMID:11745875
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Ina
internexin neuronal intermediate filament protein, alpha
increases expression
ISO
Cytarabine results in increased expression of INA mRNA
CTD
PMID:21198554
NCBI chr19:47,003,120...47,013,766
Ensembl chr19:47,003,137...47,013,766
G
Irx5
Iroquois homeobox 5
increases expression
ISO
Cytarabine results in increased expression of IRX5 mRNA
CTD
PMID:21198554
NCBI chr 8:93,084,424...93,088,084
Ensembl chr 8:93,084,253...93,102,914
G
Itgb5
integrin beta 5
decreases expression
ISO
Cytarabine results in decreased expression of ITGB5 mRNA
CTD
PMID:21198554
NCBI chr16:33,650,021...33,769,708
Ensembl chr16:33,650,035...33,769,708
G
Itm2c
integral membrane protein 2C
decreases expression
ISO
Cytarabine results in decreased expression of ITM2C mRNA
CTD
PMID:21198554
NCBI chr 1:85,822,231...85,836,419
Ensembl chr 1:85,822,002...85,836,396
G
Jam2
junction adhesion molecule 2
increases expression
ISO
Cytarabine results in increased expression of JAM2 mRNA
CTD
PMID:21198554
NCBI chr16:84,571,011...84,623,268
Ensembl chr16:84,571,011...84,622,816
G
Jun
jun proto-oncogene
increases expression
ISO
Cytarabine results in increased expression of JUN; Cytarabine results in increased expression of JUN mRNA
CTD
PMID:1450413 PMID:7949469
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kank4
KN motif and ankyrin repeat domains 4
decreases expression
ISO
Cytarabine results in decreased expression of KANK4 mRNA
CTD
PMID:21198554
NCBI chr 4:98,643,129...98,706,295
Ensembl chr 4:98,643,135...98,705,774
G
Kcnn2
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
decreases expression
ISO
Cytarabine results in decreased expression of KCNN2 mRNA
CTD
PMID:21198554
NCBI chr18:45,401,754...45,818,954
Ensembl chr18:45,401,927...45,818,950
G
Kctd12
potassium channel tetramerisation domain containing 12
decreases expression
ISO
Cytarabine results in decreased expression of KCTD12 mRNA
CTD
PMID:21198554
NCBI chr14:103,214,017...103,220,073
Ensembl chr14:103,214,017...103,220,073
G
Kdelr3
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3
decreases expression
ISO
Cytarabine results in decreased expression of KDELR3 mRNA
CTD
PMID:21198554
NCBI chr15:79,400,609...79,411,940
Ensembl chr15:79,400,612...79,411,940
G
Kif15
kinesin family member 15
increases expression
ISO
Cytarabine results in increased expression of KIF15 mRNA
CTD
PMID:21198554
NCBI chr 9:122,780,146...122,847,798
Ensembl chr 9:122,780,111...122,847,798
G
Klhl41
kelch-like 41
decreases expression
ISO
Cytarabine results in decreased expression of KLHL41 mRNA
CTD
PMID:21198554
NCBI chr 2:69,500,464...69,514,583
Ensembl chr 2:69,500,464...69,514,574
G
Klk6
kallikrein related-peptidase 6
decreases expression
ISO
Cytarabine results in decreased expression of KLK6 mRNA
CTD
PMID:21198554
NCBI chr 7:43,473,967...43,481,219
Ensembl chr 7:43,473,923...43,481,454
G
Kmo
kynurenine 3-monooxygenase
increases response to substance
ISO
KMO results in increased susceptibility to Cytarabine
CTD
PMID:21755009
NCBI chr 1:175,459,759...175,488,419
Ensembl chr 1:175,447,947...175,489,682
G
Kmt2a
lysine (K)-specific methyltransferase 2A
increases response to substance
ISO
KMT2A gene mutant form results in increased susceptibility to Cytarabine
CTD
PMID:14712291
NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594
G
Kpna2
karyopherin subunit alpha 2
decreases expression
ISO
Cytarabine results in decreased expression of KPNA2 mRNA
CTD
PMID:17374387
NCBI chr11:106,879,455...106,890,351
Ensembl chr11:106,879,455...106,890,367
G
Krt19
keratin 19
decreases expression
ISO
Cytarabine results in decreased expression of KRT19 mRNA
CTD
PMID:21198554
NCBI chr11:100,031,636...100,036,752
Ensembl chr11:100,031,636...100,039,491
G
Krt24
keratin 24
decreases expression
ISO
Cytarabine results in decreased expression of KRT24 mRNA
CTD
PMID:21198554
NCBI chr11:99,170,785...99,176,088
Ensembl chr11:99,170,785...99,176,088
G
Krt8
keratin 8
decreases expression
ISO
Cytarabine results in decreased expression of KRT8 mRNA
CTD
PMID:21198554
NCBI chr15:101,905,146...101,912,777
Ensembl chr15:101,905,133...101,912,917
G
Kynu
kynureninase
decreases expression
ISO
Cytarabine results in decreased expression of KYNU mRNA
CTD
PMID:21198554
NCBI chr 2:43,445,270...43,572,734
Ensembl chr 2:43,445,341...43,572,734
G
Lbh
limb-bud and heart
decreases expression
ISO
Cytarabine results in decreased expression of LBH mRNA
CTD
PMID:21198554
NCBI chr17:73,225,300...73,248,941
Ensembl chr17:73,225,300...73,248,942
G
Lepr
leptin receptor
decreases expression
ISO
Cytarabine results in decreased expression of LEPR mRNA
CTD
PMID:21198554
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Lhfpl6
LHFPL tetraspan subfamily member 6
increases expression
ISO
Cytarabine results in increased expression of LHFPL6 mRNA
CTD
PMID:21198554
NCBI chr 3:52,948,968...53,169,100
Ensembl chr 3:52,948,949...53,169,100
G
Limch1
LIM and calponin homology domains 1
increases expression
ISO
Cytarabine results in increased expression of LIMCH1 mRNA
CTD
PMID:21198554
NCBI chr 5:66,903,232...67,214,502
Ensembl chr 5:66,903,170...67,214,501
G
Lmcd1
LIM and cysteine-rich domains 1
decreases expression
ISO
Cytarabine results in decreased expression of LMCD1 mRNA
CTD
PMID:21198554
NCBI chr 6:112,250,747...112,307,384
Ensembl chr 6:112,250,719...112,307,386
G
Lox
lysyl oxidase
decreases expression
ISO
Cytarabine results in decreased expression of LOX mRNA
CTD
PMID:21198554
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Loxl4
lysyl oxidase-like 4
decreases expression
ISO
Cytarabine results in decreased expression of LOXL4 mRNA
CTD
PMID:21198554
NCBI chr19:42,580,718...42,601,326
Ensembl chr19:42,582,421...42,601,252
G
Lrba
LPS-responsive beige-like anchor
decreases expression
ISO
Cytarabine results in decreased expression of LRBA mRNA
CTD
PMID:21198554
NCBI chr 3:86,130,763...86,690,001
Ensembl chr 3:86,131,987...86,689,999
G
Lrfn5
leucine rich repeat and fibronectin type III domain containing 5
decreases expression
ISO
Cytarabine results in decreased expression of LRFN5 mRNA
CTD
PMID:21198554
NCBI chr12:61,569,356...61,913,554
Ensembl chr12:61,569,936...61,905,128
G
Lrig1
leucine-rich repeats and immunoglobulin-like domains 1
increases expression
ISO
Cytarabine results in increased expression of LRIG1 mRNA
CTD
PMID:21198554
NCBI chr 6:94,581,510...94,677,205
Ensembl chr 6:94,581,510...94,677,139
G
Lrp1b
low density lipoprotein-related protein 1B
decreases expression
ISO
Cytarabine results in decreased expression of LRP1B mRNA
CTD
PMID:21198554
NCBI chr 2:40,485,302...42,543,747
Ensembl chr 2:40,485,258...42,543,636
G
Lrrc32
leucine rich repeat containing 32
decreases expression
ISO
Cytarabine results in decreased expression of LRRC32 mRNA
CTD
PMID:21198554
NCBI chr 7:98,138,515...98,151,038
Ensembl chr 7:98,138,490...98,151,388
G
Lrrc41
leucine rich repeat containing 41
decreases expression
ISO
Cytarabine results in decreased expression of LRRC41 mRNA
CTD
PMID:21198554
NCBI chr 4:115,932,466...115,954,306
Ensembl chr 4:115,932,466...115,954,240
G
Lrrn2
leucine rich repeat protein 2, neuronal
decreases expression
ISO
Cytarabine results in decreased expression of LRRN2 mRNA
CTD
PMID:21198554
NCBI chr 1:132,808,093...132,867,743
Ensembl chr 1:132,808,011...132,867,743
G
Lrrn3
leucine rich repeat protein 3, neuronal
increases expression
ISO
Cytarabine results in increased expression of LRRN3 mRNA
CTD
PMID:21198554
NCBI chr12:41,501,667...41,536,056
Ensembl chr12:41,501,667...41,536,430
G
Lrrn4
leucine rich repeat neuronal 4
decreases expression
ISO
Cytarabine results in decreased expression of LRRN4 mRNA
CTD
PMID:21198554
NCBI chr 2:132,710,436...132,735,930
Ensembl chr 2:132,710,225...132,722,811
G
Lum
lumican
decreases expression
ISO
Cytarabine results in decreased expression of LUM mRNA
CTD
PMID:21198554
NCBI chr10:97,401,363...97,408,565
Ensembl chr10:97,400,990...97,408,565
G
Ly6h
lymphocyte antigen 6 family member H
decreases expression
ISO
Cytarabine results in decreased expression of LY6H mRNA
CTD
PMID:21198554
NCBI chr15:75,436,594...75,439,114
Ensembl chr15:75,424,894...75,439,104
G
Ly75
lymphocyte antigen 75
increases expression
ISO
Cytarabine results in increased expression of LY75 mRNA
CTD
PMID:19194470
NCBI chr 2:60,122,447...60,213,617
Ensembl chr 2:60,122,447...60,213,647
G
Lyl1
lymphoblastomic leukemia 1
decreases response to substance
ISO
LYL1 protein results in decreased susceptibility to Cytarabine
CTD
PMID:16094422
NCBI chr 8:85,428,051...85,432,876
Ensembl chr 8:85,428,078...85,431,569
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
Cytarabine results in decreased expression of LYN mRNA
CTD
PMID:21198554
NCBI chr 4:3,676,865...3,791,613
Ensembl chr 4:3,678,115...3,813,122
G
Lyz2
lysozyme 2
increases expression
ISO
Cytarabine results in increased expression of LYZ mRNA
CTD
PMID:19194470
NCBI chr10:117,113,446...117,118,177
Ensembl chr10:117,113,236...117,118,226
G
Mab21l2
mab-21-like 2
decreases expression
ISO
Cytarabine results in decreased expression of MAB21L2 mRNA
CTD
PMID:21198554
NCBI chr 3:86,453,357...86,455,590
Ensembl chr 3:86,452,888...86,455,590
G
Magi1
membrane associated guanylate kinase, WW and PDZ domain containing 1
increases expression
ISO
Cytarabine results in increased expression of MAGI1 mRNA
CTD
PMID:21198554
NCBI chr 6:93,652,434...94,260,906
Ensembl chr 6:93,652,436...94,260,898
G
Map2
microtubule-associated protein 2
decreases expression increases expression
ISO
Cytarabine results in decreased expression of MAP2 protein Cytarabine results in increased expression of MAP2 mRNA
CTD
PMID:21198554
NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
G
Marchf3
membrane associated ring-CH-type finger 3
decreases expression
ISO
Cytarabine results in decreased expression of MARCHF3 mRNA
CTD
PMID:21198554
NCBI chr18:56,894,788...57,058,587
Ensembl chr18:56,894,788...57,058,620
G
Matn2
matrilin 2
decreases expression
ISO
Cytarabine results in decreased expression of MATN2 mRNA
CTD
PMID:21198554
NCBI chr15:34,306,827...34,436,388
Ensembl chr15:34,306,823...34,436,419
G
Mbtd1
mbt domain containing 1
increases expression
ISO
Cytarabine results in increased expression of MBTD1 mRNA
CTD
PMID:21198554
NCBI chr11:93,776,635...93,837,815
Ensembl chr11:93,776,678...93,837,811
G
Mcl1
myeloid cell leukemia sequence 1
decreases expression
ISO
Cytarabine results in decreased expression of MCL1 protein
CTD
PMID:16818278
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
G
Mcoln3
mucolipin 3
decreases expression
ISO
Cytarabine results in decreased expression of MCOLN3 mRNA
CTD
PMID:21198554
NCBI chr 3:145,799,032...145,847,563
Ensembl chr 3:145,823,205...145,847,561
G
Mdk
midkine
decreases expression
ISO
Cytarabine results in decreased expression of MDK mRNA
CTD
PMID:21198554
NCBI chr 2:91,760,149...91,762,348
Ensembl chr 2:91,760,150...91,762,642
G
Med9
mediator complex subunit 9
decreases expression
ISO
Cytarabine results in decreased expression of MED9 mRNA
CTD
PMID:19194470
NCBI chr11:59,839,040...59,854,132
Ensembl chr11:59,839,032...59,853,031
G
Megf10
multiple EGF-like-domains 10
increases expression
ISO
Cytarabine results in increased expression of MEGF10 mRNA
CTD
PMID:21198554
NCBI chr18:57,266,162...57,430,539
Ensembl chr18:57,266,162...57,430,539
G
Meis1
Meis homeobox 1
increases expression
ISO
Cytarabine results in increased expression of MEIS1 mRNA
CTD
PMID:21198554
NCBI chr11:18,830,428...18,968,992
Ensembl chr11:18,829,817...18,968,985
G
Mertk
MER proto-oncogene tyrosine kinase
decreases expression
ISO
Cytarabine results in decreased expression of MERTK mRNA
CTD
PMID:21198554
NCBI chr 2:128,540,836...128,645,082
Ensembl chr 2:128,540,876...128,644,814
G
Mfap4
microfibrillar-associated protein 4
decreases expression
ISO
Cytarabine results in decreased expression of MFAP4 mRNA
CTD
PMID:21198554
NCBI chr11:61,376,257...61,379,536
Ensembl chr11:61,376,257...61,379,726
G
Mgarp
mitochondria localized glutamic acid rich protein
decreases expression
ISO
Cytarabine results in decreased expression of MGARP mRNA
CTD
PMID:21198554
NCBI chr 3:51,295,833...51,303,968
Ensembl chr 3:51,295,833...51,304,159
G
Mgp
matrix Gla protein
decreases expression
ISO
Cytarabine results in decreased expression of MGP mRNA
CTD
PMID:21198554
NCBI chr 6:136,849,433...136,852,821
Ensembl chr 6:136,849,433...136,852,821
G
Mindy4
MINDY lysine 48 deubiquitinase 4
decreases expression
ISO
Cytarabine results in decreased expression of MINDY4 mRNA
CTD
PMID:21198554
NCBI chr 6:55,180,337...55,297,208
Ensembl chr 6:55,180,368...55,297,207
G
Mir22hg
Mir22 host gene (non-protein coding)
decreases expression
ISO
Cytarabine results in decreased expression of MIR22HG mRNA
CTD
PMID:21198554
NCBI chr11:75,352,365...75,357,516
Ensembl chr11:75,352,365...75,357,502
G
Mmp23
matrix metallopeptidase 23
decreases expression
ISO
Cytarabine results in decreased expression of MMP23B mRNA
CTD
PMID:21198554
NCBI chr 4:155,735,111...155,738,982
Ensembl chr 4:155,735,112...155,737,841
G
Mpzl1
myelin protein zero-like 1
decreases expression
ISO
Cytarabine results in decreased expression of MPZL1 mRNA
CTD
PMID:21198554
NCBI chr 1:165,419,745...165,462,144
Ensembl chr 1:165,419,809...165,462,107
G
Msx1
msh homeobox 1
decreases expression
ISO
Cytarabine results in decreased expression of MSX1 mRNA
CTD
PMID:21198554
NCBI chr 5:37,977,835...37,981,929
Ensembl chr 5:37,977,829...37,981,927
G
Mt1
metallothionein 1
decreases expression
ISO
Cytarabine results in decreased expression of MT1X mRNA
CTD
PMID:21198554
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
G
Mt2
metallothionein 2
decreases expression
ISO
Cytarabine results in decreased expression of MT2A mRNA
CTD
PMID:21198554
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mthfr
methylenetetrahydrofolate reductase
affects response to substance
ISO
MTHFR protein affects the susceptibility to Cytarabine
CTD
PMID:18202788
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Mtus1
mitochondrial tumor suppressor 1
increases expression
ISO
Cytarabine results in increased expression of MTUS1 mRNA
CTD
PMID:21198554
NCBI chr 8:41,443,949...41,587,318
Ensembl chr 8:41,443,951...41,586,763
G
Mvb12a
multivesicular body subunit 12A
decreases expression
ISO
Cytarabine results in decreased expression of MVB12A mRNA
CTD
PMID:21198554
NCBI chr 8:71,995,552...72,000,670
Ensembl chr 8:71,995,566...72,000,729
G
Mxd3
Max dimerization protein 3
increases expression
ISO
Cytarabine results in increased expression of MXD3 mRNA
CTD
PMID:21198554
NCBI chr13:55,472,983...55,477,937
Ensembl chr13:55,472,981...55,477,636
G
Mxra7
matrix-remodelling associated 7
decreases expression
ISO
Cytarabine results in decreased expression of MXRA7 mRNA
CTD
PMID:21198554
NCBI chr11:116,694,226...116,718,953
Ensembl chr11:116,693,888...116,718,872
G
Myadm
myeloid-associated differentiation marker
decreases expression
ISO
Cytarabine results in decreased expression of MYADM mRNA
CTD
PMID:21198554
NCBI chr 7:3,337,563...3,347,871
Ensembl chr 7:3,337,605...3,348,958
G
Mydgf
myeloid derived growth factor
decreases expression
ISO
Cytarabine results in decreased expression of MYDGF mRNA
CTD
PMID:21198554
NCBI chr17:56,483,541...56,490,920
Ensembl chr17:56,482,744...56,490,920
G
Myl4
myosin, light polypeptide 4
decreases expression
ISO
Cytarabine results in decreased expression of MYL4 mRNA
CTD
PMID:21198554
NCBI chr11:104,427,604...104,478,041
Ensembl chr11:104,441,489...104,486,579
G
Myl7
myosin, light polypeptide 7, regulatory
decreases expression
ISO
Cytarabine results in decreased expression of MYL7 mRNA
CTD
PMID:21198554
NCBI chr11:5,846,637...5,848,782
Ensembl chr11:5,846,637...5,848,782
G
Mylip
myosin regulatory light chain interacting protein
decreases expression
ISO
Cytarabine results in decreased expression of MYLIP mRNA
CTD
PMID:21198554
NCBI chr13:45,543,197...45,565,498
Ensembl chr13:45,543,218...45,565,498
G
Myof
myoferlin
decreases expression
ISO
Cytarabine results in decreased expression of MYOF mRNA
CTD
PMID:21198554
NCBI chr19:37,887,484...38,032,025
Ensembl chr19:37,887,484...38,032,025
G
Nav2
neuron navigator 2
decreases expression
ISO
Cytarabine results in decreased expression of NAV2 mRNA
CTD
PMID:21198554
NCBI chr 7:48,608,796...49,259,838
Ensembl chr 7:48,558,464...49,259,838
G
Ncald
neurocalcin delta
increases expression
ISO
Cytarabine results in increased expression of NCALD mRNA
CTD
PMID:21198554
NCBI chr15:37,366,419...37,792,816
Ensembl chr15:37,366,419...37,792,814
G
Ndc80
NDC80 kinetochore complex component
increases expression
ISO
Cytarabine results in increased expression of NDC80 mRNA
CTD
PMID:19194470
NCBI chr17:71,803,095...71,833,852
Ensembl chr17:71,803,095...71,833,852
G
Ndrg1
N-myc downstream regulated gene 1
decreases expression
ISO
Cytarabine results in decreased expression of NDRG1 mRNA
CTD
PMID:21198554
NCBI chr15:66,801,167...66,841,490
Ensembl chr15:66,801,167...66,841,489
G
Ndrg2
N-myc downstream regulated gene 2
decreases expression
ISO
Cytarabine results in decreased expression of NDRG2 mRNA
CTD
PMID:21198554
NCBI chr14:52,142,738...52,151,463
Ensembl chr14:52,142,728...52,151,615
G
Nell2
NEL-like 2
increases expression
ISO
Cytarabine results in increased expression of NELL2 mRNA
CTD
PMID:21198554
NCBI chr15:95,117,321...95,426,677
Ensembl chr15:94,973,111...95,426,440
G
Nes
nestin
increases expression decreases expression
ISO
Cytarabine results in increased expression of NES mRNA Cytarabine results in decreased expression of NES protein
CTD
PMID:21198554
NCBI chr 3:87,878,400...87,887,758
Ensembl chr 3:87,878,385...87,887,758
G
Nfib
nuclear factor I/B
increases expression
ISO
Cytarabine results in increased expression of NFIB mRNA
CTD
PMID:21198554
NCBI chr 4:82,208,410...82,424,988
Ensembl chr 4:82,208,410...82,623,987
G
Nherf1
NHERF family PDZ scaffold protein 1
decreases expression
ISO
Cytarabine results in decreased expression of NHERF1 mRNA
CTD
PMID:21198554
NCBI chr11:115,054,138...115,072,009
Ensembl chr11:115,054,167...115,072,007
G
Niban2
niban apoptosis regulator 2
decreases expression
ISO
Cytarabine results in decreased expression of NIBAN2 mRNA
CTD
PMID:21198554
NCBI chr 2:32,766,146...32,815,265
Ensembl chr 2:32,766,126...32,815,266
G
Nmu
neuromedin U
increases expression
ISO
Cytarabine results in increased expression of NMU mRNA
CTD
PMID:21198554
NCBI chr 5:76,481,342...76,511,624
Ensembl chr 5:76,481,342...76,511,635
G
Nova1
NOVA alternative splicing regulator 1
increases expression
ISO
Cytarabine results in increased expression of NOVA1 mRNA
CTD
PMID:21198554
NCBI chr12:46,744,678...46,866,143
Ensembl chr12:46,741,300...46,865,712
G
Nox4
NADPH oxidase 4
decreases expression
ISO
Cytarabine results in decreased expression of NOX4 mRNA
CTD
PMID:21198554
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
G
Nppb
natriuretic peptide type B
increases expression
ISO
Cytarabine results in increased expression of NPPB mRNA; Cytarabine results in increased expression of NPPB protein
CTD
PMID:16151589 PMID:21198554
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
G
Npy
neuropeptide Y
decreases expression
ISO
Cytarabine results in decreased expression of NPY mRNA
CTD
PMID:21198554
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Nrip3
nuclear receptor interacting protein 3
decreases expression
ISO
Cytarabine results in decreased expression of NRIP3 mRNA
CTD
PMID:21198554
NCBI chr 7:109,357,263...109,380,752
Ensembl chr 7:109,357,262...109,381,232
G
Nrp1
neuropilin 1
multiple interactions
EXP
[2,2-bis(4-glycidyloxyphenyl)propane co-treated with Cytarabine] results in decreased expression of NRP1 mRNA
CTD
PMID:23264188
NCBI chr 8:129,085,553...129,231,957
Ensembl chr 8:129,085,085...129,229,844
G
Ntm
neurotrimin
decreases expression
ISO
Cytarabine results in decreased expression of NTM mRNA
CTD
PMID:21198554
NCBI chr 9:28,906,045...29,874,565
Ensembl chr 9:28,906,046...29,874,437
G
Ntng1
netrin G1
increases expression
ISO
Cytarabine results in increased expression of NTNG1 mRNA
CTD
PMID:21198554
NCBI chr 3:109,687,366...110,057,291
Ensembl chr 3:109,687,356...110,051,327
G
Odam
odontogenic, ameloblast asssociated
decreases expression
ISO
Cytarabine results in decreased expression of ODAM mRNA
CTD
PMID:21198554
NCBI chr 5:88,032,869...88,042,668
Ensembl chr 5:88,032,888...88,042,033
G
Olfml3
olfactomedin-like 3
decreases expression
ISO
Cytarabine results in decreased expression of OLFML3 mRNA
CTD
PMID:21198554
NCBI chr 3:103,642,710...103,645,317
Ensembl chr 3:103,629,538...103,645,317
G
Olr1
oxidized low density lipoprotein (lectin-like) receptor 1
decreases expression
ISO
Cytarabine results in decreased expression of OLR1 mRNA
CTD
PMID:21198554
NCBI chr 6:129,456,113...129,484,312
Ensembl chr 6:129,462,207...129,484,128
G
Osbpl10
oxysterol binding protein-like 10
decreases expression
ISO
Cytarabine results in decreased expression of OSBPL10 mRNA
CTD
PMID:21198554
NCBI chr 9:114,807,531...115,062,341
Ensembl chr 9:114,807,637...115,061,293
G
Osr1
odd-skipped related transcription factor 1
decreases expression
ISO
Cytarabine results in decreased expression of OSR1 mRNA
CTD
PMID:21198554
NCBI chr12:9,624,442...9,631,500
Ensembl chr12:9,620,116...9,631,500
G
P4ha2
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide
decreases expression
ISO
Cytarabine results in decreased expression of P4HA2 mRNA
CTD
PMID:21198554
NCBI chr11:53,991,750...54,022,494
Ensembl chr11:53,990,921...54,022,491
G
Pals2
protein associated with LIN7 2, MAGUK family member
decreases expression
ISO
Cytarabine results in decreased expression of PALS2 mRNA
CTD
PMID:21198554
NCBI chr 6:50,087,206...50,176,134
Ensembl chr 6:50,087,221...50,175,919
G
Pamr1
peptidase domain containing associated with muscle regeneration 1
decreases expression
ISO
Cytarabine results in decreased expression of PAMR1 mRNA
CTD
PMID:21198554
NCBI chr 2:102,380,325...102,473,386
Ensembl chr 2:102,380,357...102,473,386
G
Pard6a
par-6 family cell polarity regulator alpha
decreases expression
ISO
Cytarabine results in decreased expression of PARD6A mRNA
CTD
PMID:19194470
NCBI chr 8:106,427,780...106,430,126
Ensembl chr 8:106,427,780...106,430,128
G
Parm1
prostate androgen-regulated mucin-like protein 1
decreases expression
ISO
Cytarabine results in decreased expression of PARM1 mRNA
CTD
PMID:21198554
NCBI chr 5:91,665,559...91,771,870
Ensembl chr 5:91,665,474...91,774,753
G
Parp1
poly (ADP-ribose) polymerase family, member 1
multiple interactions increases degradation
ISO
[Cytarabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein; BCL2 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein]; BCL2L1 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein]
CTD
PMID:8840993 PMID:12780785
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pax6
paired box 6
increases expression decreases expression
ISO
Cytarabine results in increased expression of PAX6 mRNA Cytarabine results in decreased expression of PAX6 protein
CTD
PMID:21198554
NCBI chr 2:105,499,241...105,528,755
Ensembl chr 2:105,499,245...105,527,709
G
Pcdh20
protocadherin 20
decreases expression
ISO
Cytarabine results in decreased expression of PCDH20 mRNA
CTD
PMID:21198554
NCBI chr14:88,702,183...88,708,832
Ensembl chr14:88,702,179...88,708,832
G
Pcdh7
protocadherin 7
decreases expression
ISO
Cytarabine results in decreased expression of PCDH7 mRNA
CTD
PMID:21198554
NCBI chr 5:57,873,487...58,290,578
Ensembl chr 5:57,875,309...58,290,572
G
Pced1b
PC-esterase domain containing 1B
decreases expression
ISO
Cytarabine results in decreased expression of PCED1B mRNA
CTD
PMID:21198554
NCBI chr15:97,143,563...97,283,574
Ensembl chr15:97,144,988...97,283,561
G
Pcsk5
proprotein convertase subtilisin/kexin type 5
decreases expression
ISO
Cytarabine results in decreased expression of PCSK5 mRNA
CTD
PMID:21198554
NCBI chr19:17,409,678...17,815,076
Ensembl chr19:17,409,683...17,814,996
G
Pde1a
phosphodiesterase 1A, calmodulin-dependent
increases expression
ISO
Cytarabine results in increased expression of PDE1A mRNA
CTD
PMID:21198554
NCBI chr 2:79,664,797...80,026,862
Ensembl chr 2:79,664,797...79,959,802
G
Pde1b
phosphodiesterase 1B, Ca2+-calmodulin dependent
increases expression
ISO
Cytarabine results in increased expression of PDE1B mRNA
CTD
PMID:21198554
NCBI chr15:103,411,461...103,438,483
Ensembl chr15:103,411,461...103,438,479
G
Pde4b
phosphodiesterase 4B, cAMP specific
increases expression
ISO
Cytarabine results in increased expression of PDE4B mRNA
CTD
PMID:21198554
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
G
Pde6d
phosphodiesterase 6D, cGMP-specific, rod, delta
decreases expression
ISO
Cytarabine results in decreased expression of PDE6D mRNA
CTD
PMID:19194470
NCBI chr 1:86,470,735...86,510,260
Ensembl chr 1:86,470,716...86,510,351
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
decreases expression
ISO
Cytarabine results in decreased expression of PDGFRB mRNA
CTD
PMID:21198554
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Pdlim3
PDZ and LIM domain 3
increases expression
ISO
Cytarabine results in increased expression of PDLIM3 mRNA
CTD
PMID:21198554
NCBI chr 8:46,338,524...46,372,672
Ensembl chr 8:46,338,498...46,372,585
G
Pdlim4
PDZ and LIM domain 4
multiple interactions
ISO
Cytarabine inhibits the reaction [decitabine results in increased expression of PDLIM4 mRNA]
CTD
PMID:17634552
NCBI chr11:53,945,754...53,959,814
Ensembl chr11:53,945,754...53,959,840
G
Pdpn
podoplanin
decreases expression
ISO
Cytarabine results in decreased expression of PDPN mRNA
CTD
PMID:21198554
NCBI chr 4:142,993,979...143,026,134
Ensembl chr 4:142,994,001...143,026,134
G
Peli1
pellino 1
increases expression
ISO
Cytarabine results in increased expression of PELI1 mRNA
CTD
PMID:21198554
NCBI chr11:21,041,283...21,100,327
Ensembl chr11:21,041,291...21,100,323
G
Pfkp
phosphofructokinase, platelet
decreases expression
ISO
Cytarabine results in decreased expression of PFKP mRNA
CTD
PMID:21198554
NCBI chr13:6,629,910...6,699,096
Ensembl chr13:6,629,804...6,698,813
G
Pgm5
phosphoglucomutase 5
decreases expression
ISO
Cytarabine results in decreased expression of PGM5 mRNA
CTD
PMID:21198554
NCBI chr19:24,655,625...24,839,206
Ensembl chr19:24,660,380...24,839,219
G
Phactr2
phosphatase and actin regulator 2
decreases expression
ISO
Cytarabine results in decreased expression of PHACTR2 mRNA
CTD
PMID:21198554
NCBI chr10:13,083,461...13,350,266
Ensembl chr10:13,083,461...13,350,156
G
Phyhipl
phytanoyl-CoA hydroxylase interacting protein-like
increases expression
ISO
Cytarabine results in increased expression of PHYHIPL mRNA
CTD
PMID:21198554
NCBI chr10:70,393,516...70,435,121
Ensembl chr10:70,393,512...70,491,795
G
Pigh
phosphatidylinositol glycan anchor biosynthesis, class H
decreases expression
ISO
Cytarabine results in decreased expression of PIGH mRNA
CTD
PMID:21198554
NCBI chr12:79,127,443...79,136,478
Ensembl chr12:79,127,438...79,136,425
G
Pitx1
paired-like homeodomain transcription factor 1
decreases expression
ISO
Cytarabine results in decreased expression of PITX1 mRNA
CTD
PMID:21198554
NCBI chr13:55,972,857...55,984,002
Ensembl chr13:55,972,864...55,984,005
G
Pitx2
paired-like homeodomain transcription factor 2
decreases expression
ISO
Cytarabine results in decreased expression of PITX2 mRNA
CTD
PMID:21198554
NCBI chr 3:128,993,527...129,013,243
Ensembl chr 3:128,993,527...129,013,240
G
Pkia
protein kinase inhibitor, alpha
decreases expression
ISO
Cytarabine results in decreased expression of PKIA mRNA
CTD
PMID:21198554
NCBI chr 3:7,431,695...7,510,426
Ensembl chr 3:7,431,729...7,510,426
G
Pkp2
plakophilin 2
decreases expression
ISO
Cytarabine results in decreased expression of PKP2 mRNA
CTD
PMID:21198554
NCBI chr16:16,031,209...16,090,576
Ensembl chr16:16,031,182...16,090,576
G
Plac9
placenta specific 9
decreases expression
ISO
Cytarabine results in decreased expression of PLAC9 mRNA
CTD
PMID:21198554
NCBI chr14:25,888,356...25,903,339
Ensembl chr14:25,887,930...25,903,524
G
Plat
plasminogen activator, tissue
decreases expression
ISO
Cytarabine results in decreased expression of PLAT mRNA
CTD
PMID:21198554
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plcb2
phospholipase C, beta 2
affects localization multiple interactions
ISO
Cytarabine affects the localization of PLCB2 protein edelfosine inhibits the reaction [Cytarabine affects the localization of PLCB2 protein]
CTD
PMID:9295281
NCBI chr 2:118,535,484...118,559,140
Ensembl chr 2:118,537,998...118,558,919
G
Plch1
phospholipase C, eta 1
increases expression
ISO
Cytarabine results in increased expression of PLCH1 mRNA
CTD
PMID:21198554
NCBI chr 3:63,603,620...63,806,929
Ensembl chr 3:63,603,655...63,806,893
G
Pld3
phospholipase D family member 3
decreases expression
ISO
Cytarabine results in decreased expression of PLD3 mRNA
CTD
PMID:21198554
NCBI chr 7:27,231,090...27,252,511
Ensembl chr 7:27,231,425...27,252,643
G
Plekhg3
pleckstrin homology domain containing, family G (with RhoGef domain) member 3
decreases expression
ISO
Cytarabine results in decreased expression of PLEKHG3 mRNA
CTD
PMID:21198554
NCBI chr12:76,580,330...76,627,265
Ensembl chr12:76,577,665...76,627,262
G
Plg
plasminogen
affects localization
ISO
Cytarabine affects the localization of PLG protein
CTD
PMID:12165291
NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
G
Plin3
perilipin 3
decreases expression
ISO
Cytarabine results in decreased expression of PLIN3 mRNA
CTD
PMID:21198554
NCBI chr17:56,585,962...56,597,511
Ensembl chr17:56,584,476...56,599,873
G
Pllp
plasma membrane proteolipid
decreases expression
ISO
Cytarabine results in decreased expression of PLLP mRNA
CTD
PMID:21198554
NCBI chr 8:95,401,523...95,422,870
Ensembl chr 8:95,401,522...95,422,906
G
Plod1
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1
decreases expression
ISO
Cytarabine results in decreased expression of PLOD1 mRNA
CTD
PMID:21198554
NCBI chr 4:147,994,210...148,021,233
Ensembl chr 4:147,994,210...148,021,224
G
Plp1
proteolipid protein (myelin) 1
increases expression
ISO
Cytarabine results in increased expression of PLP1 mRNA
CTD
PMID:21198554
NCBI chr X:135,720,897...135,739,331
Ensembl chr X:135,723,420...135,740,482
G
Pltp
phospholipid transfer protein
decreases expression
ISO
Cytarabine results in decreased expression of PLTP mRNA
CTD
PMID:21198554
NCBI chr 2:164,681,441...164,699,564
Ensembl chr 2:164,681,438...164,699,631
G
Pmel
premelanosome protein
increases expression
ISO
Cytarabine results in increased expression of PMEL mRNA
CTD
PMID:21198554
NCBI chr10:128,531,757...128,555,993
Ensembl chr10:128,540,064...128,556,107
G
Pmp22
peripheral myelin protein 22
decreases expression
ISO
Cytarabine results in decreased expression of PMP22 mRNA
CTD
PMID:21198554
NCBI chr11:63,019,808...63,050,373
Ensembl chr11:63,019,808...63,050,373
G
Podxl
podocalyxin-like
decreases expression
ISO
Cytarabine results in decreased expression of PODXL mRNA
CTD
PMID:21198554
NCBI chr 6:31,496,428...31,540,872
Ensembl chr 6:31,496,423...31,540,916
G
Podxl2
podocalyxin-like 2
increases expression
ISO
Cytarabine results in increased expression of PODXL2 mRNA
CTD
PMID:21198554
NCBI chr 6:88,819,539...88,852,063
Ensembl chr 6:88,819,540...88,852,026
G
Postn
periostin, osteoblast specific factor
decreases expression
ISO
Cytarabine results in decreased expression of POSTN mRNA
CTD
PMID:21198554
NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions increases expression
EXP
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA]
CTD
PMID:23264188
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppic
peptidylprolyl isomerase C
decreases expression
ISO
Cytarabine results in decreased expression of PPIC mRNA
CTD
PMID:21198554
NCBI chr18:53,539,413...53,551,079
Ensembl chr18:53,539,404...53,551,187
G
Ppm1m
protein phosphatase 1M
decreases expression
ISO
Cytarabine results in decreased expression of PPM1M mRNA
CTD
PMID:21198554
NCBI chr 9:106,072,152...106,076,432
Ensembl chr 9:106,072,146...106,076,945
G
Ppt2
palmitoyl-protein thioesterase 2
decreases expression
ISO
Cytarabine results in decreased expression of PPT2 mRNA
CTD
PMID:21198554
NCBI chr17:34,835,636...34,856,993
Ensembl chr17:34,835,636...34,847,484
G
Prc1
protein regulator of cytokinesis 1
decreases expression
ISO
Cytarabine results in decreased expression of PRC1 mRNA
CTD
PMID:17374387
NCBI chr 7:79,944,224...79,966,007
Ensembl chr 7:79,944,198...79,966,007
G
Prdm8
PR domain containing 8
increases expression
ISO
Cytarabine results in increased expression of PRDM8 mRNA
CTD
PMID:21198554
NCBI chr 5:98,315,241...98,335,313
Ensembl chr 5:98,315,057...98,336,850
G
Prickle1
prickle planar cell polarity protein 1
decreases expression
ISO
Cytarabine results in decreased expression of PRICKLE1 mRNA
CTD
PMID:21198554
NCBI chr15:93,396,992...93,494,147
Ensembl chr15:93,396,995...93,493,772
G
Prkcz
protein kinase C, zeta
decreases response to substance
ISO
PRKCZ protein results in decreased susceptibility to Cytarabine
CTD
PMID:21863889
NCBI chr 4:155,344,579...155,445,856
Ensembl chr 4:155,344,586...155,445,818
G
Prl
prolactin
increases expression
ISO
Cytarabine results in increased expression of PRL protein
CTD
PMID:8312290
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Prnp
prion protein
decreases expression
ISO
Cytarabine results in decreased expression of PRNP mRNA
CTD
PMID:21198554
NCBI chr 2:131,751,848...131,780,356
Ensembl chr 2:131,751,848...131,780,349
G
Prph
peripherin
decreases expression
ISO
Cytarabine results in decreased expression of PRPH mRNA
CTD
PMID:21198554
NCBI chr15:98,951,452...98,956,858
Ensembl chr15:98,953,055...98,956,859
G
Prrc2c
proline-rich coiled-coil 2C
decreases expression
ISO
Cytarabine results in decreased expression of PRRC2C mRNA
CTD
PMID:19194470
NCBI chr 1:162,499,354...162,568,125
Ensembl chr 1:162,498,294...162,568,125
G
Prss35
serine protease 35
decreases expression
ISO
Cytarabine results in decreased expression of PRSS35 mRNA
CTD
PMID:21198554
NCBI chr 9:86,625,291...86,640,496
Ensembl chr 9:86,625,702...86,640,496
G
Psd3
pleckstrin and Sec7 domain containing 3
increases expression
ISO
Cytarabine results in increased expression of PSD3 mRNA
CTD
PMID:21198554
NCBI chr 8:68,141,728...68,664,740
Ensembl chr 8:68,141,734...68,664,679
G
Psrc1
proline/serine-rich coiled-coil 1
decreases expression
ISO
Cytarabine results in decreased expression of PSRC1 mRNA
CTD
PMID:17374387
NCBI chr 3:108,291,120...108,295,547
Ensembl chr 3:108,291,155...108,295,547
G
Pstpip2
proline-serine-threonine phosphatase-interacting protein 2
decreases expression
ISO
Cytarabine results in decreased expression of PSTPIP2 mRNA
CTD
PMID:19194470
NCBI chr18:77,882,250...77,971,462
Ensembl chr18:77,877,614...77,970,579
G
Pten
phosphatase and tensin homolog
increases response to substance
ISO
PTEN protein results in increased susceptibility to Cytarabine
CTD
PMID:22185283
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP ISO
PTGS2 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine] PTGS2 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]
CTD
PMID:24184161
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Pth1r
parathyroid hormone 1 receptor
decreases expression
ISO
Cytarabine results in decreased expression of PTH1R mRNA
CTD
PMID:21198554
NCBI chr 9:110,551,132...110,576,213
Ensembl chr 9:110,551,153...110,576,213
G
Ptprz1
protein tyrosine phosphatase receptor type Z, polypeptide 1
increases expression
ISO
Cytarabine results in increased expression of PTPRZ1 mRNA
CTD
PMID:21198554
NCBI chr 6:22,875,302...23,052,915
Ensembl chr 6:22,875,501...23,052,915
G
Qprt
quinolinate phosphoribosyltransferase
decreases expression
ISO
Cytarabine results in decreased expression of QPRT mRNA
CTD
PMID:21198554
NCBI chr 7:126,706,942...126,721,201
Ensembl chr 7:126,706,286...126,721,398
G
Rab37
RAB37, member RAS oncogene family
decreases expression
ISO
Cytarabine results in decreased expression of RAB37 mRNA
CTD
PMID:21198554
NCBI chr11:114,982,257...115,053,066
Ensembl chr11:114,982,257...115,053,062
G
Rab5b
RAB5B, member RAS oncogene family
increases expression
ISO
Cytarabine results in increased expression of RAB5B mRNA
CTD
PMID:19194470
NCBI chr10:128,511,980...128,532,160
Ensembl chr10:128,513,044...128,532,133
G
Rabggtb
Rab geranylgeranyl transferase, b subunit
decreases expression
ISO
Cytarabine results in decreased expression of RABGGTB mRNA
CTD
PMID:19194470
NCBI chr 3:153,612,926...153,618,603
Ensembl chr 3:153,612,924...153,618,646
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
Cytarabine results in decreased expression of RAD23A mRNA
CTD
PMID:19194470
NCBI chr 8:85,561,540...85,567,361
Ensembl chr 8:85,560,648...85,567,294
G
Rad51
RAD51 recombinase
increases expression
ISO
Cytarabine results in increased expression of RAD51 mRNA
CTD
PMID:19194470
NCBI chr 2:118,943,295...118,966,554
Ensembl chr 2:118,943,274...118,977,926
G
Ramp1
receptor (calcitonin) activity modifying protein 1
decreases expression
ISO
Cytarabine results in decreased expression of RAMP1 mRNA
CTD
PMID:21198554
NCBI chr 1:91,107,544...91,152,918
Ensembl chr 1:91,107,544...91,152,918
G
Rassf2
Ras association (RalGDS/AF-6) domain family member 2
increases expression
ISO
Cytarabine results in increased expression of RASSF2 mRNA
CTD
PMID:21198554
NCBI chr 2:131,834,770...131,872,336
Ensembl chr 2:131,831,335...131,872,178
G
Rbm34
RNA binding motif protein 34
decreases expression
ISO
Cytarabine results in decreased expression of RBM34 mRNA
CTD
PMID:19194470
NCBI chr 8:127,673,922...127,697,799
Ensembl chr 8:127,673,922...127,697,821
G
Recql5
RecQ protein-like 5
decreases expression
ISO
Cytarabine results in decreased expression of RECQL5 mRNA
CTD
PMID:19194470
NCBI chr11:115,783,421...115,824,339
Ensembl chr11:115,783,421...115,824,303
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions decreases activity decreases phosphorylation
ISO
calyculin A inhibits the reaction [Cytarabine results in decreased activity of RELA protein] Cytarabine results in decreased phosphorylation of RELA protein
CTD
PMID:12853972
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Reln
reelin
decreases expression
ISO
Cytarabine results in decreased expression of RELN mRNA
CTD
PMID:21198554
NCBI chr 5:22,089,452...22,549,703
Ensembl chr 5:22,089,452...22,549,700
G
Rerg
RAS-like, estrogen-regulated, growth-inhibitor
decreases expression
ISO
Cytarabine results in decreased expression of RERG mRNA
CTD
PMID:21198554
NCBI chr 6:137,031,822...137,147,494
Ensembl chr 6:137,031,823...137,147,495
G
Rexo4
REX4, 3'-5' exonuclease
decreases expression
ISO
Cytarabine results in decreased expression of REXO4 mRNA
CTD
PMID:21198554
NCBI chr 2:26,843,575...26,854,398
Ensembl chr 2:26,843,575...26,854,398
G
Rgl1
ral guanine nucleotide dissociation stimulator,-like 1
decreases expression
ISO
Cytarabine results in decreased expression of RGL1 mRNA
CTD
PMID:21198554
NCBI chr 1:152,392,513...152,642,056
Ensembl chr 1:152,392,511...152,642,102
G
Rgmb
repulsive guidance molecule family member B
increases expression
ISO
Cytarabine results in increased expression of RGMB mRNA
CTD
PMID:21198554
NCBI chr17:16,024,923...16,051,508
Ensembl chr17:16,023,450...16,051,301
G
Rgs1
regulator of G-protein signaling 1
decreases expression
ISO
Cytarabine results in decreased expression of RGS1 mRNA
CTD
PMID:21198554
NCBI chr 1:144,120,407...144,124,862
Ensembl chr 1:144,118,034...144,124,980
G
Rgs13
regulator of G-protein signaling 13
decreases expression
ISO
Cytarabine results in decreased expression of RGS13 mRNA
CTD
PMID:21198554
NCBI chr 1:144,013,083...144,053,240
Ensembl chr 1:144,014,392...144,053,110
G
Rgs20
regulator of G-protein signaling 20
increases expression
ISO
Cytarabine results in increased expression of RGS20 mRNA
CTD
PMID:21198554
NCBI chr 1:4,976,342...5,140,528
Ensembl chr 1:4,979,799...5,140,508
G
Rgs4
regulator of G-protein signaling 4
decreases expression
ISO
Cytarabine results in decreased expression of RGS4 mRNA
CTD
PMID:21198554
NCBI chr 1:169,569,046...169,575,211
Ensembl chr 1:169,569,046...169,575,211
G
Rhoc
ras homolog family member C
decreases expression
ISO
Cytarabine results in decreased expression of RHOC mRNA
CTD
PMID:21198554
NCBI chr 3:104,696,350...104,701,775
Ensembl chr 3:104,695,691...104,701,775
G
Rhpn2
rhophilin, Rho GTPase binding protein 2
decreases expression
ISO
Cytarabine results in decreased expression of RHPN2 mRNA
CTD
PMID:21198554
NCBI chr 7:35,033,605...35,091,712
Ensembl chr 7:35,033,595...35,091,714
G
Robo3
roundabout guidance receptor 3
increases expression
ISO
Cytarabine results in increased expression of ROBO3 mRNA
CTD
PMID:21198554
NCBI chr 9:37,327,341...37,344,730
Ensembl chr 9:37,326,965...37,344,542
G
Rpp25
ribonuclease P/MRP 25 subunit
decreases expression
ISO
Cytarabine results in decreased expression of RPP25 mRNA
CTD
PMID:21198554
NCBI chr 9:57,411,385...57,412,730
Ensembl chr 9:57,411,309...57,412,731
G
Rprml
reprimo-like
increases expression
ISO
Cytarabine results in increased expression of RPRML mRNA
CTD
PMID:21198554
NCBI chr11:103,540,335...103,541,406
Ensembl chr11:103,540,396...103,541,405
G
Rras
related RAS viral (r-ras) oncogene
decreases expression
ISO
Cytarabine results in decreased expression of RRAS mRNA
CTD
PMID:21198554
NCBI chr 7:44,665,686...44,671,070
Ensembl chr 7:44,667,385...44,671,071
G
Rrm2
ribonucleotide reductase M2
increases expression
ISO
Cytarabine results in increased expression of RRM2 mRNA
CTD
PMID:19194470
NCBI chr12:24,758,253...24,764,145
Ensembl chr12:24,758,240...24,764,145
G
Rspo2
R-spondin 2
decreases expression
ISO
Cytarabine results in decreased expression of RSPO2 mRNA
CTD
PMID:21198554
NCBI chr15:42,884,184...43,034,990
Ensembl chr15:42,884,190...43,034,222
G
Rsrp1
arginine/serine rich protein 1
decreases expression
ISO
Cytarabine results in decreased expression of RSRP1 mRNA
CTD
PMID:21198554
NCBI chr 4:134,650,936...134,654,681
Ensembl chr 4:134,650,903...134,654,982
G
Rtn1
reticulon 1
increases expression
ISO
Cytarabine results in increased expression of RTN1 mRNA
CTD
PMID:21198554
NCBI chr12:72,258,523...72,455,828
Ensembl chr12:72,258,526...72,455,828
G
Rwdd1
RWD domain containing 1
increases expression
ISO
Cytarabine results in increased expression of RWDD1 mRNA
CTD
PMID:21198554
NCBI chr10:33,872,551...33,895,612
Ensembl chr10:33,872,551...33,895,620
G
S100a10
S100 calcium binding protein A10 (calpactin)
decreases expression
ISO
Cytarabine results in decreased expression of S100A10 mRNA
CTD
PMID:21198554
NCBI chr 3:93,462,424...93,471,952
Ensembl chr 3:93,462,387...93,471,950
G
S100a4
S100 calcium binding protein A4
decreases expression
ISO
Cytarabine results in decreased expression of S100A4 mRNA
CTD
PMID:21198554
NCBI chr 3:90,511,077...90,513,349
Ensembl chr 3:90,511,078...90,513,352
G
Saraf
store-operated calcium entry-associated regulatory factor
decreases expression
ISO
Cytarabine results in decreased expression of SARAF mRNA
CTD
PMID:21198554
NCBI chr 8:34,621,733...34,638,001
Ensembl chr 8:34,621,717...34,637,999
G
Sbspon
somatomedin B and thrombospondin, type 1 domain containing
decreases expression
ISO
Cytarabine results in decreased expression of SBSPON mRNA
CTD
PMID:21198554
NCBI chr 1:15,924,086...15,962,946
Ensembl chr 1:15,924,086...15,962,946
G
Scamp5
secretory carrier membrane protein 5
increases expression
ISO
Cytarabine results in increased expression of SCAMP5 mRNA
CTD
PMID:21198554
NCBI chr 9:57,348,610...57,375,343
Ensembl chr 9:57,348,610...57,375,343
G
Scyl1
SCY1-like 1 (S. cerevisiae)
decreases expression
ISO
Cytarabine results in decreased expression of SCYL1 mRNA
CTD
PMID:21198554
NCBI chr19:5,808,450...5,821,461
Ensembl chr19:5,808,379...5,821,447
G
Sdc4
syndecan 4
decreases expression
ISO
Cytarabine results in decreased expression of SDC4 mRNA
CTD
PMID:21198554
NCBI chr 2:164,266,167...164,285,512
Ensembl chr 2:164,266,167...164,285,807
G
Sec14l1
SEC14-like lipid binding 1
decreases expression
ISO
Cytarabine results in decreased expression of SEC14L1 mRNA
CTD
PMID:21198554
NCBI chr11:117,005,994...117,050,094
Ensembl chr11:117,005,994...117,050,094
G
Selenom
selenoprotein M
decreases expression
ISO
Cytarabine results in decreased expression of SELENOM mRNA
CTD
PMID:21198554
NCBI chr11:3,464,684...3,467,351
Ensembl chr11:3,464,684...3,467,351
G
Sema5b
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B
increases expression
ISO
Cytarabine results in increased expression of SEMA5B mRNA
CTD
PMID:21198554
NCBI chr16:35,361,517...35,485,103
Ensembl chr16:35,361,515...35,485,102
G
Serpinb6a
serine (or cysteine) peptidase inhibitor, clade B, member 6a
decreases expression
ISO
Cytarabine results in decreased expression of SERPINB6 mRNA
CTD
PMID:21198554
NCBI chr13:34,101,901...34,186,777
Ensembl chr13:34,101,901...34,186,777
G
Serpinb9
serine (or cysteine) peptidase inhibitor, clade B, member 9
decreases expression
ISO
Cytarabine results in decreased expression of SERPINB9 mRNA
CTD
PMID:21198554
NCBI chr13:33,181,044...33,201,938
Ensembl chr13:33,187,233...33,201,940
G
Serpinh1
serine (or cysteine) peptidase inhibitor, clade H, member 1
decreases expression
ISO
Cytarabine results in decreased expression of SERPINH1 mRNA
CTD
PMID:21198554
NCBI chr 7:98,994,583...99,002,321
Ensembl chr 7:98,994,583...99,002,446
G
Sertad1
SERTA domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of SERTAD1 mRNA
CTD
PMID:21198554
NCBI chr 7:27,186,378...27,189,741
Ensembl chr 7:27,186,335...27,189,741
G
Sesn3
sestrin 3
decreases expression
ISO
Cytarabine results in decreased expression of SESN3 mRNA
CTD
PMID:33770205
NCBI chr 9:14,187,597...14,237,430
Ensembl chr 9:14,186,363...14,244,397
G
Sfn
stratifin
decreases response to substance
ISO
SFN protein results in decreased susceptibility to Cytarabine
CTD
PMID:25189999
NCBI chr 4:133,327,867...133,329,163
Ensembl chr 4:133,327,867...133,329,479
G
Sfrp1
secreted frizzled-related protein 1
increases expression
ISO
Cytarabine results in increased expression of SFRP1 mRNA
CTD
PMID:21198554
NCBI chr 8:23,901,401...23,939,648
Ensembl chr 8:23,901,518...23,939,648
G
Sfrp2
secreted frizzled-related protein 2
increases expression
ISO
Cytarabine results in increased expression of SFRP2 mRNA
CTD
PMID:21198554
NCBI chr 3:83,673,628...83,681,621
Ensembl chr 3:83,673,628...83,681,623
G
Sgip1
SH3-domain GRB2-like (endophilin) interacting protein 1
increases expression
ISO
Cytarabine results in increased expression of SGIP1 mRNA
CTD
PMID:21198554
NCBI chr 4:102,616,351...102,834,623
Ensembl chr 4:102,598,494...102,830,825
G
Sh3rf2
SH3 domain containing ring finger 2
decreases expression
ISO
Cytarabine results in decreased expression of SH3RF2 mRNA
CTD
PMID:21198554
NCBI chr18:42,185,531...42,291,760
Ensembl chr18:42,186,732...42,292,025
G
Sipa1l2
signal-induced proliferation-associated 1 like 2
decreases expression
ISO
Cytarabine results in decreased expression of SIPA1L2 mRNA
CTD
PMID:21198554
NCBI chr 8:126,144,807...126,296,602
Ensembl chr 8:126,144,802...126,296,547
G
Sla
src-like adaptor
increases expression
ISO
Cytarabine results in increased expression of SLA mRNA
CTD
PMID:19194470
NCBI chr15:66,652,713...66,703,921
Ensembl chr15:66,652,668...66,703,678
G
Slc12a6
solute carrier family 12, member 6
decreases expression
ISO
Cytarabine results in decreased expression of SLC12A6 mRNA
CTD
PMID:33770205
NCBI chr 2:112,096,659...112,193,508
Ensembl chr 2:112,096,170...112,193,508
G
Slc16a3
solute carrier family 16 (monocarboxylic acid transporters), member 3
decreases expression
ISO
Cytarabine results in decreased expression of SLC16A3 mRNA
CTD
PMID:21198554
NCBI chr11:120,839,310...120,849,826
Ensembl chr11:120,839,306...120,851,694
G
Slc16a9
solute carrier family 16 (monocarboxylic acid transporters), member 9
increases expression
ISO
Cytarabine results in increased expression of SLC16A9 mRNA
CTD
PMID:21198554
NCBI chr10:70,081,106...70,121,781
Ensembl chr10:70,080,930...70,121,798
G
Slc17a6
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6
increases expression
ISO
Cytarabine results in increased expression of SLC17A6 mRNA
CTD
PMID:21198554
NCBI chr 7:51,271,578...51,320,874
Ensembl chr 7:51,271,754...51,320,867
G
Slc28a1
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1
multiple interactions
ISO
Cytarabine inhibits the reaction [SLC28A1 protein results in increased transport of Uridine] Cytarabine inhibits the reaction [SLC28A1 protein results in increased uptake of Uridine]
CTD
PMID:8713072 PMID:10772724
NCBI chr 7:80,763,017...80,820,164
Ensembl chr 7:80,764,547...80,820,164
G
Slc29a1
solute carrier family 29 (nucleoside transporters), member 1
decreases response to substance
ISO
SLC29A1 gene polymorphism results in decreased susceptibility to Cytarabine
CTD
PMID:18381442
NCBI chr17:45,896,126...45,910,544
Ensembl chr17:45,896,126...45,910,532
G
Slc2a1
solute carrier family 2 (facilitated glucose transporter), member 1
decreases expression
ISO
Cytarabine results in decreased expression of SLC2A1 mRNA
CTD
PMID:21198554
NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
G
Slc39a2
solute carrier family 39 (zinc transporter), member 2
decreases expression
ISO
Cytarabine results in decreased expression of SLC39A2 mRNA
CTD
PMID:21198554
NCBI chr14:52,130,539...52,134,202
Ensembl chr14:52,130,346...52,134,202
G
Slc40a1
solute carrier family 40 (iron-regulated transporter), member 1
decreases expression
ISO
Cytarabine results in decreased expression of SLC40A1 mRNA
CTD
PMID:21198554
NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683
G
Slc43a3
solute carrier family 43, member 3
increases expression
ISO
Cytarabine results in increased expression of SLC43A3 mRNA
CTD
PMID:19194470
NCBI chr 2:84,766,943...84,788,853
Ensembl chr 2:84,766,923...84,788,853
G
Slc47a1
solute carrier family 47, member 1
decreases expression
ISO
Cytarabine results in decreased expression of SLC47A1 mRNA
CTD
PMID:21198554
NCBI chr11:61,234,226...61,269,668
Ensembl chr11:61,234,227...61,269,171
G
Slc4a8
solute carrier family 4 (anion exchanger), member 8
decreases expression
ISO
Cytarabine results in decreased expression of SLC4A8 mRNA
CTD
PMID:21198554
NCBI chr15:100,659,628...100,721,852
Ensembl chr15:100,659,628...100,721,849
G
Slc5a12
solute carrier family 5 (sodium/glucose cotransporter), member 12
decreases expression
ISO
Cytarabine results in decreased expression of SLC5A12 mRNA
CTD
PMID:21198554
NCBI chr 2:110,427,644...110,479,690
Ensembl chr 2:110,427,643...110,478,124
G
Slc7a2
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2
decreases expression
ISO
Cytarabine results in decreased expression of SLC7A2 mRNA
CTD
PMID:21198554
NCBI chr 8:41,315,404...41,375,107
Ensembl chr 8:41,315,433...41,375,345
G
Slc7a7
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7
decreases expression
ISO
Cytarabine results in decreased expression of SLC7A7 mRNA
CTD
PMID:21198554
NCBI chr14:54,606,899...54,657,525
Ensembl chr14:54,606,899...54,655,237
G
Slfn9
schlafen 9
increases expression
ISO
Cytarabine results in increased expression of SLFN11 mRNA
CTD
PMID:21198554
NCBI chr11:82,865,142...82,883,041
Ensembl chr11:82,869,216...82,882,656
G
Slit2
slit guidance ligand 2
decreases expression
ISO
Cytarabine results in decreased expression of SLIT2 mRNA
CTD
PMID:21198554
NCBI chr 5:48,138,633...48,465,077
Ensembl chr 5:48,140,480...48,465,075
G
Slitrk3
SLIT and NTRK-like family, member 3
decreases expression
ISO
Cytarabine results in decreased expression of SLITRK3 mRNA
CTD
PMID:21198554
NCBI chr 3:72,954,399...72,965,298
Ensembl chr 3:72,954,598...72,965,136
G
Slitrk5
SLIT and NTRK-like family, member 5
decreases expression
ISO
Cytarabine results in decreased expression of SLITRK5 mRNA
CTD
PMID:19194470
NCBI chr14:111,912,547...111,920,576
Ensembl chr14:111,912,529...111,920,573
G
Sln
sarcolipin
decreases expression
ISO
Cytarabine results in decreased expression of SLN mRNA
CTD
PMID:21198554
NCBI chr 9:53,757,535...53,761,133
Ensembl chr 9:53,757,448...53,761,844
G
Smad6
SMAD family member 6
decreases expression
ISO
Cytarabine results in decreased expression of SMAD6 mRNA
CTD
PMID:21198554
NCBI chr 9:63,860,358...63,929,374
Ensembl chr 9:63,860,358...63,929,341
G
Smoc2
SPARC related modular calcium binding 2
decreases expression
ISO
Cytarabine results in decreased expression of SMOC2 mRNA
CTD
PMID:21198554
NCBI chr17:14,499,768...14,625,052
Ensembl chr17:14,499,768...14,625,052
G
Smpdl3a
sphingomyelin phosphodiesterase, acid-like 3A
decreases expression
ISO
Cytarabine results in decreased expression of SMPDL3A mRNA
CTD
PMID:21198554
NCBI chr10:57,670,640...57,687,926
Ensembl chr10:57,670,431...57,687,926
G
Snai2
snail family zinc finger 2
decreases expression
ISO
Cytarabine results in decreased expression of SNAI2 mRNA
CTD
PMID:21198554
NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249
G
Snap91
synaptosomal-associated protein 91
increases expression
ISO
Cytarabine results in increased expression of SNAP91 mRNA
CTD
PMID:21198554
NCBI chr 9:86,647,976...86,762,766
Ensembl chr 9:86,647,976...86,762,707
G
Snca
synuclein, alpha
multiple interactions
ISO
Cytarabine promotes the reaction [SNCA protein mutant form results in increased susceptibility to ferrous chloride]; Cytarabine promotes the reaction [SNCA protein mutant form results in increased susceptibility to Iron]
CTD
PMID:14535945
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
G
Snd1
staphylococcal nuclease and tudor domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of SND1 mRNA
CTD
PMID:21198554
NCBI chr 6:28,480,332...28,935,161
Ensembl chr 6:28,475,138...28,935,161
G
Snf8
SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)
decreases expression
ISO
Cytarabine results in decreased expression of SNF8 mRNA
CTD
PMID:21198554
NCBI chr11:95,925,711...95,938,256
Ensembl chr11:95,925,711...95,938,256
G
Sorbs2
sorbin and SH3 domain containing 2
increases expression
ISO
Cytarabine results in increased expression of SORBS2 mRNA
CTD
PMID:21198554
NCBI chr 8:45,960,470...46,280,943
Ensembl chr 8:45,960,825...46,280,943
G
Sox21
SRY (sex determining region Y)-box 21
increases expression
ISO
Cytarabine results in increased expression of SOX21 mRNA
CTD
PMID:21198554
NCBI chr14:118,470,645...118,474,442
Ensembl chr14:118,470,644...118,474,442
G
Sox3
SRY (sex determining region Y)-box 3
increases expression
ISO
Cytarabine results in increased expression of SOX3 mRNA
CTD
PMID:21198554
NCBI chr X:59,934,972...59,937,045
Ensembl chr X:59,934,972...59,937,036
G
Spag16
sperm associated antigen 16
increases expression
ISO
Cytarabine results in increased expression of SPAG16 mRNA
CTD
PMID:21198554
NCBI chr 1:69,866,031...70,764,291
Ensembl chr 1:69,866,129...70,764,291
G
Sparc
secreted acidic cysteine rich glycoprotein
decreases expression
ISO
Cytarabine results in decreased expression of SPARC mRNA
CTD
PMID:21198554
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Spata7
spermatogenesis associated 7
increases expression
ISO
Cytarabine results in increased expression of SPATA7 mRNA
CTD
PMID:21198554
NCBI chr12:98,594,169...98,636,078
Ensembl chr12:98,594,416...98,636,074
G
Spin4
spindlin family, member 4
decreases expression
ISO
Cytarabine results in decreased expression of SPIN4 mRNA
CTD
PMID:21198554
NCBI chr X:94,066,113...94,070,288
Ensembl chr X:94,066,116...94,070,288
G
Spink1
serine peptidase inhibitor, Kazal type 1
increases expression
ISO
Cytarabine results in increased expression of SPINK1 mRNA
CTD
PMID:21198554
NCBI chr18:43,861,134...43,870,302
Ensembl chr18:43,861,147...43,870,622
G
Spon1
spondin 1, (f-spondin) extracellular matrix protein
decreases expression
ISO
Cytarabine results in decreased expression of SPON1 mRNA
CTD
PMID:21198554
NCBI chr 7:113,365,235...113,642,610
Ensembl chr 7:113,365,235...113,642,605
G
Sptlc3
serine palmitoyltransferase, long chain base subunit 3
decreases expression
ISO
Cytarabine results in decreased expression of SPTLC3 mRNA
CTD
PMID:21198554
NCBI chr 2:139,335,833...139,478,981
Ensembl chr 2:139,335,833...139,479,594
G
Srgap3
SLIT-ROBO Rho GTPase activating protein 3
increases expression
ISO
Cytarabine results in increased expression of SRGAP3 mRNA
CTD
PMID:21198554 PMID:33770205
NCBI chr 6:112,694,932...112,924,466
Ensembl chr 6:112,694,932...112,924,227
G
Srgn
serglycin
increases expression
ISO
Cytarabine results in increased expression of SRGN mRNA
CTD
PMID:19194470
NCBI chr10:62,329,612...62,363,224
Ensembl chr10:62,329,612...62,363,230
G
Srxn1
sulfiredoxin 1 homolog (S. cerevisiae)
increases expression
EXP
Cytarabine results in increased expression of SRXN1 mRNA
CTD
PMID:22003191
NCBI chr 2:151,946,738...151,953,296
Ensembl chr 2:151,947,436...151,953,296
G
Ssu2
ssu-2 homolog
increases expression
ISO
Cytarabine results in increased expression of SSUH2 mRNA
CTD
PMID:21198554
NCBI chr 6:112,336,283...112,365,160
Ensembl chr 6:112,336,285...112,364,984
G
St18
suppression of tumorigenicity 18
increases expression
ISO
Cytarabine results in increased expression of ST18 mRNA
CTD
PMID:21198554
NCBI chr 1:6,557,455...6,931,164
Ensembl chr 1:6,557,455...6,931,164
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
decreases expression
ISO
Cytarabine results in decreased expression of ST3GAL1 mRNA
CTD
PMID:21198554
NCBI chr15:66,974,724...67,048,575
Ensembl chr15:66,974,724...67,048,679
G
St3gal5
ST3 beta-galactoside alpha-2,3-sialyltransferase 5
decreases expression
ISO
Cytarabine results in decreased expression of ST3GAL5 mRNA
CTD
PMID:33770205
NCBI chr 6:72,074,555...72,131,555
Ensembl chr 6:72,074,576...72,131,555
G
St3gal6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
decreases expression
ISO
Cytarabine results in decreased expression of ST3GAL6 mRNA
CTD
PMID:21198554
NCBI chr16:58,290,105...58,344,614
Ensembl chr16:58,288,488...58,344,606
G
St6galnac3
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3
decreases expression
ISO
Cytarabine results in decreased expression of ST6GALNAC3 mRNA
CTD
PMID:21198554
NCBI chr 3:152,903,911...153,430,804
Ensembl chr 3:152,903,903...153,430,811
G
St6galnac6
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6
decreases expression
ISO
Cytarabine results in decreased expression of ST6GALNAC6 mRNA
CTD
PMID:21198554
NCBI chr 2:32,489,721...32,510,821
Ensembl chr 2:32,489,721...32,510,818
G
Stmn4
stathmin-like 4
increases response to substance
ISO
STMN4 results in increased susceptibility to Cytarabine
CTD
PMID:21755009
NCBI chr14:66,581,806...66,599,129
Ensembl chr14:66,581,745...66,599,129
G
Stom
stomatin
decreases expression
ISO
Cytarabine results in decreased expression of STOM mRNA
CTD
PMID:21198554
NCBI chr 2:35,204,002...35,227,021
Ensembl chr 2:35,203,998...35,226,988
G
Ston1
stonin 1
decreases expression
ISO
Cytarabine results in decreased expression of STON1 mRNA
CTD
PMID:21198554
NCBI chr17:88,905,043...88,955,293
Ensembl chr17:88,905,112...88,970,014
G
Surf4
surfeit gene 4
decreases expression
ISO
Cytarabine results in decreased expression of SURF4 mRNA
CTD
PMID:21198554
NCBI chr 2:26,810,052...26,823,801
Ensembl chr 2:26,810,052...26,823,940
G
Svep1
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1
decreases expression
ISO
Cytarabine results in decreased expression of SVEP1 mRNA
CTD
PMID:21198554
NCBI chr 4:58,042,796...58,206,596
Ensembl chr 4:58,042,442...58,206,859
G
Sytl2
synaptotagmin-like 2
increases expression
ISO
Cytarabine results in increased expression of SYTL2 mRNA
CTD
PMID:21198554
NCBI chr 7:89,951,421...90,059,927
Ensembl chr 7:89,951,460...90,059,927
G
Tac1
tachykinin 1
increases expression
ISO
Cytarabine results in increased expression of TAC1 mRNA
CTD
PMID:21198554
NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
G
Tac2
tachykinin 2
decreases expression
ISO
Cytarabine results in decreased expression of TAC3 mRNA
CTD
PMID:21198554
NCBI chr10:127,560,347...127,567,637
Ensembl chr10:127,560,347...127,567,637
G
Tagln
transgelin
increases expression
ISO
Cytarabine results in increased expression of TAGLN mRNA
CTD
PMID:21198554
NCBI chr 9:45,840,926...45,847,356
Ensembl chr 9:45,840,917...45,847,356
G
Tbc1d4
TBC1 domain family, member 4
decreases expression
ISO
Cytarabine results in decreased expression of TBC1D4 mRNA
CTD
PMID:21198554
NCBI chr14:101,679,800...101,846,717
Ensembl chr14:101,679,796...101,846,627
G
Tceal7
transcription elongation factor A (SII)-like 7
increases expression
ISO
Cytarabine results in increased expression of TCEAL7 mRNA
CTD
PMID:21198554
NCBI chr X:135,124,790...135,126,849
Ensembl chr X:135,115,528...135,126,849
G
Tcf12
transcription factor 12
increases expression
ISO
Cytarabine results in increased expression of TCF12 mRNA
CTD
PMID:21198554
NCBI chr 9:71,751,534...72,019,611
Ensembl chr 9:71,749,970...72,019,153
G
Tcf21
transcription factor 21
decreases expression
ISO
Cytarabine results in decreased expression of TCF21 mRNA
CTD
PMID:21198554
NCBI chr10:22,693,162...22,696,042
Ensembl chr10:22,693,180...22,696,073
G
Tcf25
transcription factor 25 (basic helix-loop-helix)
decreases expression
ISO
Cytarabine results in decreased expression of TCF25 mRNA
CTD
PMID:21198554
NCBI chr 8:124,097,511...124,130,913
Ensembl chr 8:124,100,492...124,130,574
G
Tecrl
trans-2,3-enoyl-CoA reductase-like
decreases expression
ISO
Cytarabine results in decreased expression of TECRL mRNA
CTD
PMID:21198554
NCBI chr 5:83,425,969...83,503,042
Ensembl chr 5:83,425,992...83,503,042
G
Tek
TEK receptor tyrosine kinase
decreases expression
ISO
Cytarabine results in decreased expression of TEK mRNA
CTD
PMID:21198554
NCBI chr 4:94,627,322...94,763,213
Ensembl chr 4:94,627,526...94,763,213
G
Tent5a
terminal nucleotidyltransferase 5A
decreases expression
ISO
Cytarabine results in decreased expression of TENT5A mRNA
CTD
PMID:21198554
NCBI chr 9:85,202,492...85,209,203
Ensembl chr 9:85,202,492...85,209,401
G
Tent5c
terminal nucleotidyltransferase 5C
decreases expression
ISO
Cytarabine results in decreased expression of TENT5C mRNA
CTD
PMID:21198554
NCBI chr 3:100,375,373...100,396,508
Ensembl chr 3:100,358,944...100,396,640
G
Tfap2a
transcription factor AP-2, alpha
multiple interactions increases expression
EXP
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of TFAP2A mRNA]
CTD
PMID:23264188
NCBI chr13:40,867,278...40,891,715
Ensembl chr13:40,868,778...40,891,852
G
Tfe3
transcription factor E3
increases expression
ISO
Cytarabine results in increased expression of TFE3 mRNA
CTD
PMID:19194470
NCBI chr X:7,628,769...7,641,441
Ensembl chr X:7,628,799...7,641,441
G
Tff3
trefoil factor 3, intestinal
increases expression
ISO
Cytarabine results in increased expression of TFF3 mRNA
CTD
PMID:21198554
NCBI chr17:31,344,280...31,348,585
Ensembl chr17:31,344,280...31,348,620
G
Tfpi
tissue factor pathway inhibitor
decreases expression
ISO
Cytarabine results in decreased expression of TFPI mRNA
CTD
PMID:21198554
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Tgfbr3
transforming growth factor, beta receptor III
decreases expression
ISO
Cytarabine results in decreased expression of TGFBR3 mRNA
CTD
PMID:21198554
NCBI chr 5:107,254,433...107,437,495
Ensembl chr 5:107,254,436...107,437,495
G
Th
tyrosine hydroxylase
decreases expression
ISO
Cytarabine results in decreased expression of TH protein
CTD
PMID:21198554
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
G
Thbs1
thrombospondin 1
increases expression
ISO
Cytarabine results in increased expression of THBS1 mRNA
CTD
PMID:21198554
NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
G
Thy1
thymus cell antigen 1, theta
decreases expression
ISO
Cytarabine results in decreased expression of THY1 mRNA
CTD
PMID:19194470
NCBI chr 9:43,954,681...43,959,876
Ensembl chr 9:43,954,681...43,959,876
G
Timp1
tissue inhibitor of metalloproteinase 1
decreases expression
ISO
Cytarabine results in decreased expression of TIMP1 mRNA
CTD
PMID:21198554
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Timp3
tissue inhibitor of metalloproteinase 3
affects response to substance decreases response to substance
ISO
TIMP3 protein affects the susceptibility to Cytarabine TIMP3 gene modified form results in decreased susceptibility to Cytarabine
CTD
PMID:18202788
NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
G
Tk1
thymidine kinase 1
decreases activity decreases expression
ISO
Cytarabine results in decreased activity of TK1 protein Cytarabine results in decreased expression of TK1 mRNA
CTD
PMID:12893260
NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918
G
Tk2
thymidine kinase 2, mitochondrial
decreases expression decreases activity
ISO
Cytarabine results in decreased expression of TK2 mRNA Cytarabine results in decreased activity of TK2 protein
CTD
PMID:12893260
NCBI chr 8:104,953,323...104,975,224
Ensembl chr 8:104,953,317...104,975,190
G
Tln2
talin 2
decreases expression
ISO
Cytarabine results in decreased expression of TLN2 mRNA
CTD
PMID:21198554
NCBI chr 9:67,124,371...67,541,357
Ensembl chr 9:67,124,369...67,466,985
G
Tmed1
transmembrane p24 trafficking protein 1
decreases expression
ISO
Cytarabine results in decreased expression of TMED1 mRNA
CTD
PMID:21198554
NCBI chr 9:21,418,676...21,421,530
Ensembl chr 9:21,418,849...21,421,548
G
Tmed9
transmembrane p24 trafficking protein 9
decreases expression
ISO
Cytarabine results in decreased expression of TMED9 mRNA
CTD
PMID:21198554
NCBI chr13:55,740,948...55,745,510
Ensembl chr13:55,721,545...55,745,510
G
Tmem200a
transmembrane protein 200A
decreases expression
ISO
Cytarabine results in decreased expression of TMEM200A mRNA
CTD
PMID:21198554
NCBI chr10:25,867,080...25,955,713
Ensembl chr10:25,788,229...25,954,950
G
Tmem45a
transmembrane protein 45a
decreases expression
ISO
Cytarabine results in decreased expression of TMEM45A mRNA
CTD
PMID:21198554
NCBI chr16:56,625,524...56,706,648
Ensembl chr16:56,625,524...56,706,529
G
Tmem62
transmembrane protein 62
increases expression
ISO
Cytarabine results in increased expression of TMEM62 mRNA
CTD
PMID:21198554
NCBI chr 2:120,806,959...120,838,333
Ensembl chr 2:120,807,498...120,838,333
G
Tmem88
transmembrane protein 88
decreases expression
ISO
Cytarabine results in decreased expression of TMEM88 mRNA
CTD
PMID:21198554
NCBI chr11:69,287,342...69,289,060
Ensembl chr11:69,287,345...69,289,060
G
Tmem98
transmembrane protein 98
decreases expression
ISO
Cytarabine results in decreased expression of TMEM98 mRNA
CTD
PMID:21198554
NCBI chr11:80,701,192...80,712,859
Ensembl chr11:80,701,001...80,712,859
G
Tnf
tumor necrosis factor
increases expression
ISO
Cytarabine results in increased expression of TNF protein
CTD
PMID:8318674 PMID:11745875
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfaip3
tumor necrosis factor, alpha-induced protein 3
decreases expression
ISO
Cytarabine results in decreased expression of TNFAIP3 mRNA
CTD
PMID:21198554
NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
G
Tnfrsf19
tumor necrosis factor receptor superfamily, member 19
decreases expression
ISO
Cytarabine results in decreased expression of TNFRSF19 mRNA
CTD
PMID:33770205
NCBI chr14:61,201,283...61,284,304
Ensembl chr14:61,201,324...61,283,939
G
Tnfsf10
tumor necrosis factor (ligand) superfamily, member 10
multiple interactions increases expression
ISO
[Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP3 protein; [Cytarabine co-treated with TNFSF10 protein] results in increased activity of CASP8 protein; [Cytarabine co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein; [Cytarabine co-treated with TNFSF10 protein] results in increased expression of BID protein; Cytarabine promotes the reaction [TNFSF10 protein results in increased activity of CASP8 protein]; Cytarabine promotes the reaction [TNFSF10 protein results in increased expression of TNFRSF10B protein] Cytarabine results in increased expression of TNFSF10 mRNA
CTD
PMID:12780785 PMID:18549619 PMID:19194470
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
G
Tnnt2
troponin T2, cardiac
decreases expression
ISO
Cytarabine results in decreased expression of TNNT2 mRNA
CTD
PMID:21198554
NCBI chr 1:135,763,933...135,780,006
Ensembl chr 1:135,764,092...135,779,998
G
Tnrc6a
trinucleotide repeat containing 6a
increases expression
ISO
Cytarabine results in increased expression of TNRC6A mRNA
CTD
PMID:21198554
NCBI chr 7:122,630,324...122,794,519
Ensembl chr 7:122,723,108...122,794,519
G
Tpk1
thiamine pyrophosphokinase
decreases expression
ISO
Cytarabine results in decreased expression of TPK1 mRNA
CTD
PMID:21198554
NCBI chr 6:43,316,510...43,644,726
Ensembl chr 6:43,321,935...43,643,212
G
Tpst1
protein-tyrosine sulfotransferase 1
decreases expression
ISO
Cytarabine results in decreased expression of TPST1 mRNA
CTD
PMID:21198554
NCBI chr 5:130,102,167...130,164,575
Ensembl chr 5:130,102,167...130,164,570
G
Trim5
tripartite motif-containing 5
decreases expression
ISO
Cytarabine results in decreased expression of TRIM5 mRNA
CTD
PMID:21198554
NCBI chr 7:103,912,593...103,937,448
Ensembl chr 7:103,912,593...103,937,301
G
Trim6
tripartite motif-containing 6
decreases expression
ISO
Cytarabine results in decreased expression of TRIM6 mRNA
CTD
PMID:21198554
NCBI chr 7:103,868,002...103,884,359
Ensembl chr 7:103,868,000...103,884,359
G
Trp53
transformation related protein 53
multiple interactions increases phosphorylation increases expression increases response to substance affects response to substance increases activity affects activity
ISO EXP
[fludarabine co-treated with Cytarabine co-treated with docetaxel] results in increased expression of TP53 protein; Caffeine inhibits the reaction [Cytarabine results in increased expression of TP53 protein]; Caffeine inhibits the reaction [Cytarabine results in increased phosphorylation of TP53 protein] [Cytarabine results in increased expression of TP53 protein] which results in increased expression of BAX protein; Cytarabine results in increased expression of TP53 protein TP53 gene mutant form results in increased susceptibility to Cytarabine TRP53 protein affects the susceptibility to Cytarabine Cytarabine results in increased activity of TP53 protein Cytarabine affects the activity of TP53 protein; Cytarabine metabolite affects the activity of TP53 protein
CTD
PMID:9703875 PMID:9880587 PMID:10200513 PMID:12082016 PMID:12781215 PMID:14766721 PMID:15203180 PMID:17977830 PMID:19628630 PMID:20477944 PMID:22010212 PMID:22212197 PMID:24675086 PMID:35435491 More...
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trp53i11
transformation related protein 53 inducible protein 11
increases response to substance
ISO
TP53I11 results in increased susceptibility to Cytarabine
CTD
PMID:21755009
NCBI chr 2:93,017,694...93,032,102
Ensembl chr 2:93,017,893...93,032,104
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
affects localization
ISO
Cytarabine affects the localization of TRPV1 protein
CTD
PMID:18414789
NCBI chr11:73,124,975...73,152,148
Ensembl chr11:73,125,118...73,152,068
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
decreases expression
ISO
Cytarabine results in decreased expression of TRPV2 mRNA
CTD
PMID:21198554
NCBI chr11:62,465,312...62,491,131
Ensembl chr11:62,465,312...62,491,341
G
Tspan4
tetraspanin 4
decreases expression
ISO
Cytarabine results in decreased expression of TSPAN4 mRNA
CTD
PMID:21198554
NCBI chr 7:141,055,194...141,073,340
Ensembl chr 7:141,055,153...141,073,340
G
Tspo
translocator protein
decreases expression
ISO
Cytarabine results in decreased expression of TSPO mRNA
CTD
PMID:21198554
NCBI chr15:83,447,774...83,458,404
Ensembl chr15:83,447,793...83,458,404
G
Tst
thiosulfate sulfurtransferase, mitochondrial
decreases expression
ISO
Cytarabine results in decreased expression of TST mRNA
CTD
PMID:21198554
NCBI chr15:78,283,756...78,290,065
Ensembl chr15:78,283,756...78,290,107
G
Ttyh1
tweety family member 1
increases expression
ISO
Cytarabine results in increased expression of TTYH1 mRNA
CTD
PMID:21198554
NCBI chr 7:4,122,418...4,139,206
Ensembl chr 7:4,122,407...4,139,707
G
Tubb3
tubulin, beta 3 class III
decreases expression
ISO
Cytarabine results in decreased expression of TUBB3 protein
CTD
PMID:21198554
NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754
G
Tyms
thymidylate synthase
increases activity affects response to substance
EXP ISO
Cytarabine results in increased activity of TYMS protein TYMS gene polymorphism affects the susceptibility to Cytarabine
CTD
PMID:15713801 PMID:15816533
NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
G
U2af1
U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 1
decreases expression
ISO
Cytarabine results in decreased expression of U2AF1 mRNA
CTD
PMID:21198554
NCBI chr17:31,866,055...31,878,122
Ensembl chr17:31,866,055...31,877,866
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
Cytarabine results in decreased expression of UBE2C mRNA
CTD
PMID:17374387
NCBI chr 2:164,611,849...164,614,822
Ensembl chr 2:164,611,818...164,620,742
G
Ubl3
ubiquitin-like 3
increases expression
ISO
Cytarabine results in increased expression of UBL3 mRNA
CTD
PMID:19194470
NCBI chr 5:148,441,441...148,489,689
Ensembl chr 5:148,441,445...148,489,599
G
Usp7
ubiquitin specific peptidase 7
decreases expression
ISO
Cytarabine results in decreased expression of USP7 mRNA
CTD
PMID:19194470
NCBI chr16:8,506,586...8,574,931
Ensembl chr16:8,507,459...8,610,172
G
Vasn
vasorin
decreases expression
ISO
Cytarabine results in decreased expression of VASN mRNA
CTD
PMID:21198554
NCBI chr16:4,457,809...4,469,030
Ensembl chr16:4,457,805...4,468,666
G
Vcam1
vascular cell adhesion molecule 1
increases expression
ISO
Cytarabine results in increased expression of VCAM1 mRNA
CTD
PMID:21198554
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
affects response to substance
ISO
VDR gene polymorphism affects the susceptibility to Cytarabine
CTD
PMID:15713801
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Vegfc
vascular endothelial growth factor C
multiple interactions decreases response to substance
ISO EXP
EDN1 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]; PTGS2 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine] EDN1 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]; PTGS2 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine]
CTD
PMID:24184161
NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
G
Vezf1
vascular endothelial zinc finger 1
increases expression
ISO
Cytarabine results in increased expression of VEZF1 mRNA
CTD
PMID:19194470
NCBI chr11:87,959,084...87,975,555
Ensembl chr11:87,959,105...87,975,555
G
Vgll4
vestigial like family member 4
decreases expression
ISO
Cytarabine results in decreased expression of VGLL4 mRNA
CTD
PMID:21198554
NCBI chr 6:114,836,850...114,946,932
Ensembl chr 6:114,837,589...114,946,955
G
Vrk2
vaccinia related kinase 2
decreases expression
ISO
Cytarabine results in decreased expression of VRK2 mRNA
CTD
PMID:21198554
NCBI chr11:26,421,398...26,544,006
Ensembl chr11:26,421,322...26,543,999
G
Wfdc3
WAP four-disulfide core domain 3
decreases expression
ISO
Cytarabine results in decreased expression of WFDC3 mRNA
CTD
PMID:21198554
NCBI chr 2:164,573,222...164,587,914
Ensembl chr 2:164,573,100...164,587,851
G
Wipf1
WAS/WASL interacting protein family, member 1
decreases expression
ISO
Cytarabine results in decreased expression of WIPF1 mRNA
CTD
PMID:21198554
NCBI chr 2:73,259,954...73,359,831
Ensembl chr 2:73,259,954...73,360,078
G
Xiap
X-linked inhibitor of apoptosis
increases response to substance
ISO
XIAP protein results in increased susceptibility to Cytarabine
CTD
PMID:10815900
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
G
Xrcc1
X-ray repair complementing defective repair in Chinese hamster cells 1
increases expression
ISO
Cytarabine results in increased expression of XRCC1 mRNA
CTD
PMID:19194470
NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
G
Yif1a
Yip1 interacting factor homolog A (S. cerevisiae)
decreases expression
ISO
Cytarabine results in decreased expression of YIF1A mRNA
CTD
PMID:21198554
NCBI chr19:5,138,566...5,142,907
Ensembl chr19:5,138,566...5,142,909
G
Zc3hav1
zinc finger CCCH type, antiviral 1
decreases expression
ISO
Cytarabine results in decreased expression of ZC3HAV1 mRNA
CTD
PMID:21198554
NCBI chr 6:38,282,221...38,332,859
Ensembl chr 6:38,282,221...38,331,538
G
Zfhx4
zinc finger homeodomain 4
increases expression
ISO
Cytarabine results in increased expression of ZFHX4 mRNA
CTD
PMID:21198554
NCBI chr 3:5,276,268...5,480,921
Ensembl chr 3:5,283,586...5,480,917
G
Zfp282
zinc finger protein 282
increases expression
ISO
Cytarabine results in increased expression of ZNF282 mRNA
CTD
PMID:33770205
NCBI chr 6:47,853,433...47,885,419
Ensembl chr 6:47,854,138...47,885,419
G
Zfp383
zinc finger protein 383
increases expression
ISO
Cytarabine results in increased expression of ZNF383 mRNA
CTD
PMID:33770205
NCBI chr 7:29,607,705...29,616,238
Ensembl chr 7:29,607,648...29,616,238
G
Zfp423
zinc finger protein 423
increases expression
ISO
Cytarabine results in increased expression of ZNF423 mRNA
CTD
PMID:21198554
NCBI chr 8:88,388,438...88,688,665
Ensembl chr 8:88,388,438...88,686,223
G
Zfp467
zinc finger protein 467
decreases expression
ISO
Cytarabine results in decreased expression of ZNF467 mRNA
CTD
PMID:21198554
NCBI chr 6:48,404,626...48,422,926
Ensembl chr 6:48,404,631...48,422,759
G
Zfpm2
zinc finger protein, multitype 2
decreases expression
ISO
Cytarabine results in decreased expression of ZFPM2 mRNA
CTD
PMID:21198554
NCBI chr15:40,518,438...40,967,988
Ensembl chr15:40,518,431...40,967,988
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all